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A Study of Epithelial Cl- Secretion in the Murine Distal Colon 
Trey S. Rottgen 
Colonic epithelium has an on-going basal level of Cl- secretion, which is 
necessary for maintaining a properly hydrated epithelial mucus layer, and the 
movement of waste products. However, alterations in the level of Cl- secretion 
can have significant effects. Loss of colonic Cl- secretion, such as that seen in 
Cystic Fibrosis or ulcerative colitis can result in intestinal obstruction. While 
infection with Vibrio cholera or increased activity of the Enteric nervous system 
(ENS) can result in increased Cl- secretion and resultant diarrhea. In this study, 
we decided to evaluate both sides of the spectrum via an animal model of 
inflammatory bowel disease, and study ENS regulation of epithelial Cl- secretion. 
Ulcerative colitis (UC) is well-characterized to have a significant 
attenuation in colonic Cl- secretion. An animal model of UC, which utilizes the 
epithelial irritant dextran-sulfate sodium (DSS), has also been shown to have 
significantly blunted epithelial Cl- secretion. More specifically, previous 
observations have demonstrated the loss of Ca2+-activated Cl- secretion. 
Therefore in our study, we examined Ca2+-activated Cl- secretion in murine distal 
colon mounted in Ussing chamber. A subset of animals underwent a chronic 
induction model of DSS-colitis. Animals that received DSS  demonstrated a loss 
of Ca2+-activated Cl- secretion when stimulated with carbochol in Ussing chamber 
experiments. Protein isolated from colonic epithelium of DSS-colitis animals 
demonstrated a significant decrease in the Ca2+-activated Cl- channel, 
TMEM16A. This would indicate that loss of TMEM16A in colonic epithelium 
following DSS-treatment contributes to the observed loss of Ca2+-activated Cl- 
secretion in functional studies. 
ENS activity has previously been observed to contribute to the measured 
Cl- secretion in colonic epithelium. Therefore, we decided to evaluate the efficacy 
of KCNQ K+ channel activators to hyperpolarize and decrease enteric neuronal 
signaling. Flupirtine, a pan-KCNQ activator, was able to significantly inhibit on-
going Cl- secretion measured as a function of short-circuit current (ISC) in Ussing 
chamber preparations. Application of tetrodotoxin (TTX), following flupirtine, was 
unable to inhibit Cl- secretion, however reversal of order of application resulted in 
a significant inhibition of Cl- secretion via TTX. Immunofluorescence studies also 
demonstrated the co-localization of KCNQ2 and KCNQ3 with axons of enteric 
neurons positively-labeled with choline acetyltransferase. From these results, we 
conclude that activation of KCNQ2 and KCNQ3 in enteric neurons is able to 
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The function of the large intestine (colon) is primarily to absorb water from 
the lumen, participate in electrolyte homeostasis, and propel waste forward for 
elimination in the form of feces.  
 For the average adult, the colon absorbs approximately 1.5-2 liters of 
water each day [1]. This can increase to as much as 5-6 liters of water absorption 
in the circumstance of increased volume presentation [2]. However, volumes 
exceeding this limit or presentation of a large bulk volume will result in diarrhea. 
Water absorption is heavily reliant on electrolyte transport in the colon, as 
evidenced by several pathologies that lead to excess luminal electrolytes and 
resultant water loss [3]. However, the relative contribution of the paracellular 
versus transcellular pathways is still under investigation [4]. 
Electrolyte transport within the colon is accomplished via movement 
through a paracellular and transcellular pathway [1]. Paracellular movement 
makes up the largest component, however as contents progress distally within 
the colon, the transcellular component increases [1]. The paracellular component 
is simply movement of electrolytes down a concentration gradient, but the 
transcellular movement is performed via a myriad of transporters and ion 
channels that line the colonic mucosa. Together, the two pathways are able to 
absorb approximately 100 mmol/L of Na+ each day, with an astounding upper 
limit of 400 mmol/L per day [5].  
Elimination of waste following water and electrolyte absorption is driven by 
a complex series of coordinated muscle contractions that propel the feces 
forward for elimination via defecation. The muscle contractions are not under 
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conscious control or even under the control of the central nervous system for the 
most part. This is primarily accomplished by a nervous system of the 
gastrointestinal tract known as the enteric nervous system [6]. 
These separate, but incredibly intermingled tasks are accomplished via an 
interaction between the absorptive surface or epithelium of the colonic mucosa 
and the enteric nervous system. The following chapter will provide greater detail 
on both the epithelial layer and enteric nervous system, as well as elaborate on 
an ion channels specific to each.  
 
Colonic Epithelium 
 The epithelial layer lining the colonic lumen consists of a simple columnar 
epithelium intermixed with mucus-secreting goblet cells [7]. The organization of 
epithelium at the level of the cell consists of an apical membrane that is exposed 
to luminal contents, and a basolateral membrane that interacts directly with the 
interstitial space. This kind of organization gives the epithelial cells a type of 
“polarity” upon differentiation that is simply the localization of different 
transporters [7]. Epithelial cells are anchored to a basement membrane and other 
epithelial cells via tight junction proteins [8]. The purpose of a “tight” epithelial 
layer is to minimize interaction between the “outside” and the host’s immune 
system [9]. Histological examination of the colonic epithelium reveals a repeating 
pattern of crypts of Lieberkuhn followed by surface cells [7]. The historical 
paradigm characterizes these different locations as secretory cells located within 
the crypts and absorptive cells localized at the surface of the mucosa [10, 11]. 
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Whether this is actually the case is debatable, however this provides an avenue 
to discuss some general electrolyte transport within the colon.  
 The primary cation that is absorbed in the colon is the monovalent Na+ ion 
[12]. In the proximal portions and to a lesser degree in distal portions of the 
colon, Na+ is absorbed via the electroneutral transporter sodium/hydrogen 
exchanger isoform 3 (NHE3) [13]. NHE3 is coupled to the down-regulated in 
adenoma (DRA) transporter that exchanges Cl- and HCO3- [14, 15]. This 
mechanism is coupled via pH changes within the cellular microenvironment that 
absorbs a single Na+ coupled with absorption of a single Cl-, while extruding a 
proton and single HCO3- molecule [14]. Upon moving to a more distal location 
within the colon, Na+ absorption changes from handling via NHE3 to the 
electrogenic, epithelial Na+ channel (ENaC) [16, 17]. The movement of Na+ 
through ENaC is mediated by a favorable electrochemical gradient that is 
generated via Na+/K+ atpase, which is located on the basolateral membrane [7]. 
The “pump” moves intracellular Na+ to the interstitial space and creates a void by 
which extracellular Na+ located on the apical side of the membrane can move 
down its electrochemical gradient [18]. Also, the movement of Na+ into the cell 
and eventual basolateral extrusion via the Na+/K+ pump causes absorption of 
water (H2O) via paracellular movement or aquaporin proteins located within 
apical membranes of colonic epithelium [19, 20].  
 While Na+ absorption is a major component of on-going electrolyte 
transport within the colon, the presence of an electrogenic anion secretion is 
present [21]. In Ussing chamber studies, the majority of observed short-circuit 
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current (ISC) can be attributed to apical anion secretion. The primary component 
of this basal anion secretion is comprised of the Cystic Fibrosis transmembrane 
regulator (CFTR) [22, 23]. The channel is so named due to its association with 
the disease Cystic Fibrosis. It was characterized to mediate the observed 
pathology in the early 1990s [24, 25]. The channel is a cAMP-sensitive Cl- 
channel that has a single-channel conductance of only 8-12 pS [26, 27]. 
However, stimulation with basolateral forskolin (FSK) can induce observable 
currrents in either whole-cell patch clamp electrophysiology or Ussing chamber. 
At the time of identification of the CFTR channel or lack thereof in CF patients, 
many researchers observed the presence of a compensatory Cl- current [28, 29]. 
This additional Cl- current seemed to be activated more through Ca2+-sensitive 
pathways instead of intracellular production of cyclic nucleotides [28-30].  
The Ca2+-activated Cl- channel (CaCC) was initially observed in Xenopus 
oocytes [31]. The channel demonstrated a slight voltage and time-dependence 
upon activation at lower Ca2+ concentrations. Also, the channel was sensitive to 
inhibition by niflumic acid with an apparent Ki of 17 µM [31]. Several potential 
CaCCs have been proposed; however practically all putative candidates did not 
demonstrate a similar electrophysiological profile to the CaCC initially described 
in Xenopus oocytes [32-34]. More recently though, three separate groups 
identified a CaCC that resembles the native current in electrophysiological terms 
[35-37]. Since the identification of this new putative CaCC, it has been named 
TMEM16A. The initial studies on TMEM16A demonstrated the channel to be 
localized to salivary and cultured human bronchial epithelial cells [35, 36]. 
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Following these initial observations, another group utilizing a global knock-out 
mouse of TMEM16A demonstrated an absence of a Ca2+-activated Cl- current in 
mouse trachea [38]. 
Similar to the reports of TMEM16A-mediating the Ca2+-activated Cl- current in 
native respiratory epithelium, the mice were also used to study colonic epithelium 
[38, 39]. Transepithelial potential [VTE] of distal colon administered basolateral 
carbachol (CCH; cholinergic agonist that increases intracellular Ca2+ 
concentration) was able to significantly hyperpolarize in Tmem16a+/+ mice [38]. 
However, Tmem16a-/- littermates were not able to respond to basolateral CCH 
administration [38]. Calculated ISC from control animals was approximately 60 
µA/cm2, while Tmem16a-/- animals had a calculated ISC of about 10 µA/cm2 [38]. 
It was not until recently that the tissue-specific [Vil1] knock-out mice of TMEM16A 
confirmed the previously observed results [40]. Similar to the global knockout 
mice, CCH-stimulated ISC was significantly less in the Tmem16a-/- animals [40].  
TMEM16A has been observed in several human colonic epithelial cell lines. 
The HT-29 and T84 cell lines have both demonstrated expression of TMEM16A, 
characterized by immunoblot [41, 42]. However, a group that employed the use 
of siRNA targeted against TMEM16A in the T84 cell line did not demonstrate a 
large decrease in ATP-stimulated ISC [43]. The only change in the measured ISC 
was the initial peak prior to the plateau phase of the trace, which would 
potentially indicate a minor role for TMEM16A in human colonic epithelium [43]. 
However, ATP-stimulated ISC in T84 cells has previously been characterized to be 
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mediated more through adenosine receptors, instead of Ca2+-increasing 
purinergic receptors [44]. 
 
Characterization of the Ca2+-activated Cl- Channel TMEM16A 
Considerable research has also focused on the physical characterization of 
TMEM16A [45-47]. One of the initial findings suggested that the final quaternary 
structure of TMEM16A existed as a dimer in the plasma membrane [48]. This 
was demonstrated with TMEM16A proteins that were fused to either GFP or 
mCherry [48]. The different TMEM16A conjugates were able to undergo 
fluorescence resonance energy transfer [FRET], which indicated a close 
proximity of the two proteins [48]. However, it was not until a couple of years later 
that the actual sequence of amino acids important for this interaction was 
identified [49]. Mutants of TMEM16A lacking an α-helix that corresponded to 
residues 161-179 were not able to form functional channels, hence the lack of 
observed Cl- currents in transfected HEK 293 cells [49].  
Shortly after this discovery, a group was able to identify several residues that 
were important for the voltage-dependence of the channel, as well as amino 
acids that participate in the Ca2+-sensitivity of TMEM16A [50]. The residues that 
confer a voltage-dependence of the channel were found to be located within the 
first intracellular loop and consisted of four repeating glutamic acid residues 
[444EEEE] [Fig. 1] [50]. Alanine substitution at these residues shifted the half-
maximal activation of the channel from 64 ± 0.9 mV to a more depolarized 
potential of ≈160 mV at 1 µM Ca2+ [50]. Also, the residues important for Ca2+-
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sensitivity were found to be located directly adjacent to the glutamic acid 
residues and consisted of a glutamic acid, alanine, valine, and lysine [448EAVK] 
[Fig. 1] [50]. Deletion of these particular residues was able to shift the Ca2+-
sensitivity drastically from 1 µM (which was able to increase open-probability at 
very hyperpolarized potentials) to 25 µM Ca2+ (which could increase open-
probability only marginally) [50]. While EAVK residues are undoubtedly important 
for channel gating, it has also been shown that glutamic acid residues [E702/705] 
are also essential for Ca2+-sensitivity of TMEM16A [Fig. 1] [51]. This was 
demonstrated by mutants of these two residues having a Ca2+-sensitivity several 
orders of magnitude less than their respective wild-type [WT] channel [[Ca2+], 20 
µM WT vs. 2 mM E702/705 M] [51]. The importance of these residues was 
confirmed by another group that mutated these same amino acids and obtained 
a channel with significantly less Ca2+-sensitivity [52]. This group was able to 
demonstrate cooperativity between these residues and the amino acids initially 
found to confer sensitivity [448EAVK] [52]. Three other acidic moieties [E650, 
E730, D734] have been shown to contribute to the Ca2+-sensitivity of TMEM16A 
[51]. Also, Scudieri et al. developed TMEM16A chimera proteins by substituting 
residues from TMEM16B [another member of the protein family, also exhibiting 
Ca2+-stimulated Cl- secretion] into the sequence of TMEM16A to determine 
potential domains necessary for Ca2+-binding [53].  The group was able to 
determine from their results that the third intracellular loop of TMEM16A 
participates in conferring Ca2+-sensitivity to the channel [53]. This was made 
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obvious by the deletion of these residues resulting in a shift of the EC50 of Ca2+ 
from 0.25 µM to 2 µM at a holding potential of +100 mV [53].  
While the previously mentioned work was essential for identifying residues 
necessary for Ca2+-binding and voltage-sensitivity [50, 51, 53], it was not until the 
crystal structure was elucidated that researchers could more clearly visualize the 
interaction of the previously mentioned residues [and several others] in Ca2+-
binding and channel gating of TMEM16A [54]. In 2014, Brunner et al. were the 
first group to generate a crystal structure of TMEM16 from Nectria haematococca 
[nhTMEM16] [54]. The conserved protein from Nectria haematococca only 
functions as a lipid scramblase, however, the protein is still sensitive to Ca2+ and 
demonstrates increased scramblase activity with increasing concentrations of 
Ca2+ [54]. The results of the study were able to demonstrate that nhTMEM16 
does in fact associate as a dimer in the plasma membrane [54]. This study also 
described a Ca2+-binding segment that was embedded within the hydrophobic 
membrane [54]. This research group was also the first one to postulate the 
possible mechanisms of ion conductance by either a single pore or double-
barreled architecture [46, 54]. Following the initial observations obtained from the 
crystal structure of nhTMEM16, two different groups were able to resolve the 
crystal structure of TMEM16A from murine origin [47, 55, 56]. This new 
information about the channel was able to illuminate important residues for 
interaction with conducting anions as well as illustrate that each monomer of 
TMEM16A was able to bind two individual Ca2+ ions [55]. Also, the greater 
resolution with the murine TMEM16A allowed for an accurate description of how 
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Ca2+-binding mediates Cl- conductance [56]. This is accomplished via a hinge 
mechanism that is dependent on a glutamic acid residue [E654] interacting with 
two Ca2+ ions that allow for opening of a single pore within the channel [56].  
As evidenced by the tremendous amount of research that has been 
conducted on the characterization of TMEM16A there is still much to be done in 
the future. Hopefully, the previous observations can be utilized to further 
characterize the channel in regard to potential protein-protein interactions, or the 
development of novel antagonists that allow for the pharmacological study of the 
channel in isolation. Also, some preliminary evidence indicates a potential role for 
the channel in several pathologies. Whatever the case, research will continue on 
the CaCC, TMEM16A.  
Enteric Nervous System 
 The enteric nervous system (ENS) in humans contains about as many 
neurons as the entire spinal cord, which is approximately 500 million neurons 
[57]. Due to the ENS containing so many neurons, it has previously been referred 
to as the “mini-brain of the gut”. Almost every neurotransmitter that has been 
identified in the central nervous system (CNS) has also been observed in the 
ENS [58]. The complexity of the ENS is so vast that the majority of the 
gastrointestinal tract can function with local control from ENS neurons, instead of 
extrinsic signals from the CNS [59, 60]. The ENS has the ability to regulate local 
blood flow in the tissue, motility of the tract, and electrolyte secretion via control 
of epithelial tissue [61]. The ENS is primarily localized to two major layers: the 
submucosal plexus and the myenteric plexus [6]. The submucosal plexus is 
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located just beneath the submucosa, while the myenteric plexus is actually 
located between the two smooth muscle layers of the GI tract (circular and 
longitudinal).  
 Whether located within the myenteric or submucosal plexus, there is a 
wide variety of neurons that contribute to the proper functioning of the 
gastrointestinal tract, however, they can be generally subdivided into afferent and 
efferent limbs of the ENS. Intrinsic primary afferent neurons (IPANs) have axons 
that sample the luminal contents for noxious stimuli that could cause harm to the 
mucosal layer, as well as, exhibiting an ability to respond to inflammatory 
mediators [62-64]. Integration of these signals can lead to a reflexive arc utilizing 
other ENS neurons or the stimulation of a centrally-mediated arc to increase 
motility and secretion to dilute and eliminate any potential hazard [61]. While the 
IPANs are sensory in function, the ENS is not without effector neurons such as 
secretomotor neurons [6]. Axons originating from the secretomotor neurons can 
stretch either in an ascending or descending longitudinal fashion as to coordinate 
an overall complex response of rhythmic muscle contractions [6, 65]. Some of 
these axons may even project to the mucosa to synapse on epithelium [66]. With 
this type of patterned distribution, the secretomotor neurons are able to 
increase/decrease contraction of the smooth muscle of the GI tract and in turn 
increase or decrease motility, as well as, signal to the epithelial layer to modify 
on-going electrolyte transport depending on the current synaptic inputs [6, 66].  
As far as signaling within the ENS, many different neurotransmitters are 
utilized regardless of whether the neuron is a secretomotor neuron or IPAN [58]. 
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However, cholinergic fibers (acetylcholine-releasing, ACh) comprise 
approximately 60% of the total fibers within the ENS [67]. In many cases, ACh is 
released along with small neuropeptides such as vasoactive intestinal peptide or 
calcitonin-gene related peptide, which contribute to the overall observed 
response [58]. ACh that is released from secretomotor neurons mediates its 
effect through muscarinic receptors located on smooth muscle or the basolateral 
surface of the epithelium. The binding of ACh to a muscarinic receptor leads to a 
transient increase in intracellular Ca2+, which may mediate a contraction of 
smooth muscle or an increase in Cl- secretion from epithelium, depending on the 
localization of release [68, 69].  
While the released neurotransmitter is the actual molecule that can 
modulate the activity of its target, it is universally understood that ion channels 
located on a neuron can regulate the release of said neurotransmitter [70, 71]. 
Previous studies have shown that blockade of voltage-sensitive Na+ channels 
(NaV) with tetrodotoxin (TTX) can prevent release of neurotransmitter via 
inhibition of the propagating action potentials [72]. Neurotransmitter release can 
also be inhibited in this same fashion from enteric neurons [73, 74]. However, the 
generation of an action potential and eventual release of a neurotransmitter is 
dependent on the cell reaching a threshold potential.  
Hyperpolarization via activation of K+ channels in neurons can prevent 
synaptic inputs from reaching a threshold potential. More specifically though, 
activation of KCNQ (KV7) channels or the “M” current in CNS neurons is able to 
cause a significant hyperpolarization and inhibition of neurotransmitter release 
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[75]. A previous group has also shown that activation of KV7 channels on 
neuronal cell membranes of the ENS can cause a dramatic hyperpolarization and 
prevent IPANs from responding to the noxious stimulus bradykinin [76]. The 
group was also able to show that distension with supraphysiological pressures 
was unable to generate an action potential when neurons were hyperpolarized 
via activation of KCNQ channels.  
Characterization of KCNQ Channels 
KCNQ channels are voltage-sensitive K+ channels (KV) [77, 78]. All 
members of the family consist of six transmembrane domains [79, 80]. The fourth 
of which is the S4 domain and confers the voltage-sensitivity to the KCNQ family, 
as well as, all voltage-sensitive K+ channels [81-83]. The group is composed of 
five different isoforms, which are simply KCNQ1-KCNQ5 [77, 84-86]. Similar to 
many other K+ channels [87-89], the KCNQ family associates in the membrane 
as a tetramer to form the functional channel [90, 91]. These channels have been 
characterized as slowly deactivating with visible currents at hyperpolarized 
potentials [92]. The family of channels are also frequently referred to as the “M” 
current. This is due to early observations that stimulating the M1 receptor would 
inhibit the visible current [93, 94]. However, stimulation of receptors for 
angiotensin II, bradykinin, or purines will cause inhibition of the current or really 
any other Gαq activation pathway [95-97]. The KCNQ family has also been 
characterized as contributing to resting membrane potential in many different cell 
types [98-101]. The channels have been functionally identified and have been 
shown to play a major role in a vast array of tissues, including vestibular hair 
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cells of the inner ear, cortical neurons, cardiac repolarization, and K+ recycling in 
respiratory and colonic epithelium [102-106]. Several pathologies, which include 
a form of deafness, a familial type of epilepsy, as well as the long QT syndrome 
in the heart have been linked to mutations in one variant or another [102, 107, 
108]. The aforementioned diseases also demonstrate the functional importance 
of KCNQ channels in cellular membranes.  
While several different isoforms of the KCNQ family exist, only a couple 
have real functional significance in neuronal tissue. KCNQ2 (KV7.2) and KCNQ3 
(KV7.3) are the primary contributors to the M current in neuronal tissue, however, 
in some peripheral circuits KCNQ5 (KV7.5) has been identified [101, 109, 110]. 
Early observations of the neuronal M current demonstrated that the current, as 
previously mentioned, could be inhibited via activation of muscarinic receptors 
[94]. The mechanism of inhibition would later be shown to be PIP2 depletion in 
the cellular membrane [111]. It was also shown that the native M current could 
dampen the excitability of neurons and therefore reduce the amount of action 
potentials [112, 113].  
In 1998, Biervert et al. was able to clone the open-reading frame of one of 
these channels, KCNQ2 [114]. The study was able to show that not only was this 
in fact a voltage-sensitive K+ channel, but mutations in the channel were directly 
linked to a neonatal seizure disorder through the cloning of a mutant isoform from 
a patient [114]. In that same year, Wang et al. was able to not only clone KCNQ2 
independently, but also clone KCNQ3 [77]. In vitro transcribed cRNA of KCNQ2 
and KCNQ3 was injected into Xenopus oocytes and voltage-clamped for 
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functional characterization [77]. KCNQ2, as previously described, had observable 
currents, however, injection of KCNQ3 alone did not produce currents above that 
of background [77]. Co-expression of the two isoforms increased the observed 
currents dramatically. Also, the co-expression of the two channels seemed to 
affect sensitivity to the inhibitor tetraethylammonium (TEA), since the previous Kd 
for KCNQ2 alone was much less than during co-expression of both channels 
(0.16 ± 0.02 mM vs. 3.5 ± 0.7 mM) [77].  More importantly though, the study was 
able to show that co-expression of the two channels resulted in a profile that was 
similar to the native M current in half-activation (-45.4 mV vs. -46.7 mV, M vs. 
KCNQ2/3) and pharmacological inhibition to XE-991 (0.98 ± 0.15 µM vs. 0.6 ± 
0.1 µM, M vs. KCNQ2/3) [77]. This was a major discovery in identifying the 
putative neuronal M current channels. 
 Animal models utilizing genetic manipulations have been very useful in 
determining the importance of KCNQ2 and KCNQ3 in neuronal physiology. In 
2005, a group utilized a dominant-negative knock-in of KCNQ2 [112]. M currents 
were significantly less than wild-type littermates. Also, spike-frequency was 
significantly increased in neurons expressing the KCNQ2 dominant-negative. 
Unfortunately, a genetic deletion model of KCNQ2 resulted in death of peri-natal 
mice within only a few hours of birth [115]. Less has been done with KCNQ3, 
however, one group did develop a model utilizing a substitution of glycine to 
valine at position 311 [116]. This specific mutation is derived from a family that 
was well characterized to have benign familial neonatal convulsions. Animals 
homozygous for this mutation demonstrated a significant attrition rate as 
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compared to heterozygotes. Elicited current upon a step protocol demonstrated a 
significantly blunted response to depolarizing potentials.    
Following some of these observations that clearly indicated KCNQ2/3 
were important to overall neuronal excitability, it was shown that the channels 
associated with ankyrin-G in axon initial segments (AIS) [117, 118]. This 
interaction was shown to be mediated via several c-terminal residues. 
Substitution of those residues in KCNQ2 (E810A, S811A, D812A) and KCNQ3 
(E837A, T838A, D839A) (Fig. 2) resulted in loss of localization to the AIS in 
cultured hippocampal neurons [118]. Shah et al. developed a small peptide that 
was able to disrupt this interaction in brain slices undergoing patch clamp 
electrophysiology [119]. Application of the ankyrin-binding-peptide (ABP) did 
result in an overall depolarization of hippocampal neurons. More interestingly 
though, the disruption in the AIS led to a dramatic reduction (7.8 ± 0.8 mV) in the 
threshold potential for generation of an action potential [119].  
Another residue that may have less importance for channel localization 
but definitely has significance in terms of modulation of channel activity is the 
residue important for binding of several pharmaceuticals such as retigabine and 
flupirtine. Both have been shown to be potent activators of native M current, as 
well as expressed KCNQ2 and KCNQ2/3 subunits [120, 121]. The substitution of 
a single tryptophan (W236 Q2/ W265 Q3) (Fig. 2) can result in complete loss of 
sensitivity to retigabine [122, 123]. The proposed mechanism is that binding to 
the tryptophan can stabilize the activation gate, which would increase activation, 
as well as, slow deactivation of the channel (Both phenomenon have been 
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observed in electrophysiology experiments) [123]. Flupirtine has not been 
scrutinized in this same way. However, the drug shares substantial homology to 
retigabine and is assumed to promote channel activation in a similar manner. 
Inflammatory bowel Disease 
  This group of diseases are characterized as inflammation along the 
gastrointestinal tract (GI), primarily occurring in the distal portions of the small 
intestine and all throughout the colon [124]. Inflammatory bowel disease (IBD) is 
primarily two different diseases, which are Crohn’s disease and ulcerative colitis. 
Crohn’s disease while normally localized to the small and large bowel can 
potentially manifest in any portion of the GI tract. Also, Crohn’s disease can elicit 
inflammation throughout the entire thickness of the bowel, ranging from the 
epithelial layer to the underlying longitudinal smooth muscle [125]. This can result 
in the formation of strictures or even bowel perforations. However, ulcerative 
colitis (UC) is only localized to the large bowel. It is clinically characterized as 
inflammation beginning within the rectum and moving proximally. In severe cases 
of pancolitis (inflammation of the entire colon), “inflammatory backwash” can 
move into the distal ileum of the small bowel causing inflammation. As far as 
inflammation within the tissue, UC is typically isolated to the mucosa (epithelium) 
and submucosa [126]. Besides differences in the location of the two diseases, 
the two pathologies also have a different profile when it comes to the 
inflammatory response. Crohn’s Disease typically has a cytokine profile that 
resembles a Th1 response, while UC is more typically a Th2 response [125, 126]. 
While this information has provided avenues for the development of new 
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therapies, the actual etiology of either disease is still unknown and under intense 
research. 
 Since tissue from a patient can only be obtained upon manifestation of the 
disease, many animal models have been utilized to more fully understand the 
pathogenesis of IBD [127]. One of the more common models utilized for IBD 
research is the dextran-sulfate sodium (DSS)-induced colitis model [128-130]. 
The model has been shown to have consistent results as well as offering ease of 
replication. Animals that undergo DSS exposure are simply administered their 
normal drinking water supplemented with 2-5% DSS [128]. The size of the 
dextran has been shown to impact the severity of colitis that develops within 
animal. The typical size that is utilized within the literature is 36,000-50,000 
daltons [131, 132]. The overall histopathological features that develop are similar 
to IBD with a large inflammatory infiltrate in the laminia propria, crypt distortion, 
and crypt abscesses [133]. However, selection of the host has been shown to 
impact the elicited inflammatory response. C57Bl/6 mice when exposed to DSS 
typically develop Th1-type response (Crohn’s disease), but Balb/c mice when 
administered DSS develop more of a Th2 inflammatory response, which is more 









Specific Aim 1: To determine if the observed absence of Ca2+-activated Cl- 
secretion in DSS-colitis is the result of the down-regulation of the Ca2+-activated 
Cl- channel, TMEM16A. To evaluate this, functional evidence will be collected 
utilizing the Ussing chamber to measure epithelial Cl- secretion from mounted 
colonic epithelium from either control or DSS-colitis mice. Also, protein 
expression/localization of TMEM16A will also be evaluated using immunoblot 
and immunohistochemistry techniques. 
 
Specific Aim 2: To determine if activation of KCNQ channels in enteric neurons 
can inhibit apical Cl- secretion via hyperpolarization and resultant inhibition of 
neurotransmitter release. Mounted colonic epithelium from murine distal colon 
will have flupirtine (KCNQ activator) applied to the basolateral membrane in the 
presence or absence of other inhibitors of the ENS. Also, co-localization via 
immunofluorescence of KCNQ2 and KCNQ3 with choline acetyl transferase will 
be carried out to determine the presence of and potential contributors to the 
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Figure 1. Schematic of TMEM16A channel protein with identified residues 
necessary for voltage and Ca2+-sensitivity. TMEM16A channel protein 
consists of 10 transmembrane domains [TMD]. The intracellular loop 
between TMD-2 and TMD-3 contains the voltage-sensitive 444EEEE residues, 
as well as, the 448EAVK residues that participate in Ca2+-sensitivity of the 
channel. The E702 and E705 residues located within the seventh TMD also 
participate in Ca2+-sensitivity of the channel. The third intracellular loop 
(shown in pink), and the residues E654, E730 and D734 have also been 









Figure 2. Schematic of KCNQ2 and KCNQ3 channels with labeled residues 
important for drug binding and channel localization. Tryptophan (W 236 Q2/ W 
265 Q3) labeled in yellow is necessary for binding of retigabine and the 
homologous drug, flupirtine. The orange box correlates to residues important for 
localization to axon initial segments (AIS). Deletion or substitution of these 
residues results in a complete loss of localization. The S4 domain is important 
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Abstract. Attenuated Ca2+-activated Cl- secretion has previously been observed 
in the model of dextran-sulfate-sodium (DSS)-induced colitis. Prior studies have 
implicated dysfunctional muscarinic signaling from basolateral membranes as the 
potential perpetrator leading to decreased Ca2+-activated Cl- secretion. However, 
in our chronic model of DSS-colitis, Chrm3 transcript (1.028 ± 0.12 vs. 1.029 ± 
0.27, p > 0.05) and CHRM3 protein expression (1.021 ± .24 vs. .928 ± .09, p > 
0.05) were unchanged. Therefore, we hypothesized that decreased CCH-
stimulated Cl- secretion in DSS-induced colitis can be attributed to a loss of Ca2+-
activated Cl- channels (CaCC) in apical membranes of colonic epithelium. To 
establish chemically-induced colitis, Balb/C mice were exposed to 4% DSS for 5 
alternating weeks to stimulate a more moderate, chronic colitis. Upon completion 
of the protocol, whole thickness sections of colon were mounted in the Ussing 
chamber under voltage-clamp conditions. DSS-induced colitis demonstrated a 
complete inhibition of basolateral administration of CCH-stimulated Cl- secretion 
that actually displayed a reversal in polarity (15.40 ± 2.22 µA/cm2 vs. -2.47±0.25 
µA/cm2). Western blot of potential CaCCs, quantified by densitometric analysis, 
demonstrated no change in bestrophin-2 (BEST2) and cystic fibrosis 
transmembrane regulator (CFTR), while Anoctamin-1 (ANO1, TMEM16A) was 
significantly down-regulated (1.001 ± 0.13 vs. 0.510 ± 0.12, p < 0.05). Our 
findings indicate that decreased expression of TMEM16A in DSS-induced colitis 




Chloride secretion in secretory epithelium has been primarily subdivided 
into cAMP-stimulated and Ca2+-activated through the use of different 
pharmacological agonists (9, 13). Aberrations in Cl- secretion have been 
observed in several pathological conditions, which include Cystic Fibrosis, Vibrio 
cholera infection, and inflammatory bowel disease (8, 14, 37). Decreased Cl- 
secretion in ulcerative colitis (UC) or animal models of UC (dextran-sulfate 
sodium; DSS) has been previously reported (10, 12). More specifically, Ca2+-
activated Cl- secretion has been shown to be decreased in the DSS-induced 
colitis animal model (3, 16, 19). Previous studies focused on this phenomenon 
concluded the attenuation to be attributable to dysfunctional muscarinic signaling 
from the basolateral surface of colonic epithelium (1, 18). However more 
recently, it has been reported to be possible perturbations in ion channel 
function/expression in colonic epithelium (16).   
Ca2+-activated Cl- channels (CaCCs) have been implicated to be involved 
in epithelial differentiation, salivary secretion and mucociliary clearance (28, 30, 
35). However initial attempts to characterize CaCCs proved difficult, as potential 
candidates did not match the biophysical properties of the native protein (15). In 
the past decade a novel CaCC, anoctamin 1 (ANO1, TMEM16A), was identified 
by three separate groups (6, 34, 40). Young et al demonstrated that injected 
siRNA to Tmem16a significantly inhibited pilocarpine (muscarinic agonist)-
stimulated salivary secretion in mice (40), while Caputo et al was able to achieve 
a similar knockdown of Ca2+-activated Cl- secretion with siRNA targeted to 
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TMEM16A in primary human bronchial epithelial cells (6). Following these 
seminal discoveries, several groups utilizing a global gene knock-out of 
Tmem16a demonstrated the absence of Ca2+-activated Cl- secretion in secretory 
epithelium isolated from trachea and colon (28, 30). However, the global deletion 
of the gene resulted in tracheal malacia and premature death of the animal (29). 
More recently, a tissue-specific knock-out of Tmem16a was developed. Isolated 
distal colon from these mice demonstrated an absence of Ca2+-activated Cl- 
secretion following CCH administration (4).  
 While TMEM16A has been identified as the primary mediator of Ca2+-
activated Cl- secretion in colonic epithelium, it has not been studied in DSS-
induced colitis. Thus, the goal of this study was to identify as to whether the 
previously described decreased Ca2+-activated Cl- secretion in colonic epithelium 
was attributable to decreased expression of TMEM16A in a DSS-induced chronic 
colitis. Our results indicate that TMEM16A protein expression is down-regulated 
in a chronic model of DSS-induced colitis and contributes to the observed loss in 









Materials and Methods 
Animals. Non-fasting male Balb/cAnNCrl mice (17 weeks old, Charles River, 
NY) were provided normal chow for the entirety of the project. Prior to the 
beginning of the 10-week project, mice (7 weeks) were randomly selected for 
either control or DSS groups, respectively. Balb/C mice selected for the DSS 
protocol were provided 4% DSS for 5 days (with 9 days of normal drinking water 
in between) for 5 alternating weeks, beginning with the first week. Animals 
utilized for the acute protocol were assigned to either control or DSS groups. 
DSS groups were administered 4.5% DSS in the drinking water for five (5) 
consecutive days followed by one day of normal drinking water. Both groups 
were then euthanized on the seventh day of the protocol. All animals used in the 
study were provided food and water ad libitum. All animals were anesthetized 
with intraperitoneal (i.p.) injection of Fatal Plus (Patterson Veterinary, SC). The 
experimental protocols used in this study were approved by the West Virginia 
University Institutional Animal Care and Use Committee.  
Histology and Immunohistochemistry. Distal colon segments were isolated 
from euthanized mice via bilateral pneumothorax. Isolated colonic segments 
were measured immediately upon removal with a constant temperature of 22-
23oC. Distal colon segments were then rinsed with phosphate-buffered saline 
(PBS) to remove any residual content and debris. Colonic segments were then 
opened longitudinally along the mesenteric border. An approximate 3 mm piece 
of segment was then cut from the intact colon and immediately placed in 10% 
neutral-buffered formalin for tissue fixation. Fixed tissue was then given to the 
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West Virginia University Translational Pathology Department for paraffin-
embedding and haemotoxylin and eosin (H&E) staining. Prepared slides 
consisted of 5 µm thick sections mounted on glass slides, followed by H&E 
staining for visualization of tissue architecture from the respective treatment 
groups. Immunohistochemistry was also performed on control and DSS tissue by 
the West Virginia University Translational Pathology Department to determine the 
localization of TMEM16A in whole thickness sections of mouse distal colon. Anti-
TMEM16A antibody (Alomone, Jerusalem, Israel) was used at a dilution of 1:100. 
Sectioned tissue was incubated at 37oC for a period of one hour in primary 
antibody. Following the initial step, tissue was incubated in goat anti-rabbit 
horseradish-peroxidase conjugated secondary antibody (1:1000) for one hour. 
Finally, a chromogenic substrate was added for visualization of immune-stained 
slides. All images were captured with the AxioImager (Carl Zeiss, Germany) on a 
20x magnification.  
Electrophysiology. Distal Colons were removed from euthanized mice via 
bilateral pneumothorax and rinsed with ice-cold PBS to clear residual contents. 
Segments were opened longitudinally along the mesenteric border to expose the 
epithelium. Full thickness tissue was then mounted on a pin slider with an oval 
aperture of 2.8 w x 11 l mm with a cross-sectional area of 0.30 cm2 and placed in 
the EasyMount Ussing chamber (Physiological Instruments, San Diego, CA) for 
electrophysiological study as previously described (26). Mounted tissue was 
bathed on both sides with Ringers’ solution (in mM: 115 NaCl, 25 NaHCO3, 2.4 
K2HPO4, 0.4 KH2PO4, 1.2 CaCl2, 1.2 MgCl2 and 10 glucose), while also being 
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continuously voltage-clamped at 0 mV to abolish any developing electrochemical 
gradient. ISC was continuously monitored with a 5 mV pulse applied to the tissue 
every 5 s to measure resistance (Ω). Transepithelial voltages (VTE) were 
calculated using Ohm’s law. 
ΔV = (ΔISC * RTE) 
Tissues were continuously maintained at 37oC and gassed with 5% CO2-95% O2 
(pH:7.4). Mounted tissue was incubated for 30 minutes with 5 µM indomethacin 
and 1 µM tetrodotoxin to inhibit prostaglandin synthesis and potentially activated 
enteric neurons, respectively. Following equilibration, 10 µM amiloride was added 
apically to inhibit minor electrogenic Na+ absorption (ENaC) in the distal colon. 
Upon reaching a steady-state, tissue was administered 100 µM carbachol (CCH) 
basolaterally to activate Gαq muscarinic receptors to indirectly activate apical 
Ca2+-activated Cl- secretion via intracellular increases in Ca2+ (11, 22). Fifteen 
minutes following CCH addition, 10 µM forskolin (FSK, adenylate cyclase 
inhibitor that increases intracellular cAMP) was basolaterally added to assess 
tissue viability. All representative traces and presented group data are 
designated as positive deflections indicating apical anion secretion/cation 
absorption or negative deflections representative of cation secretion/anion 
absorption. 
 
Colonic Epithelial Cell Isolation. Distal colons were isolated from euthanized 
mice via bilateral pneumothorax and immediately rinsed with ice-cold phosphate-
buffered saline (PBS) to clear luminal contents. The distal colon was then 
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opened longitudinally along the mesenteric border. Tissue was then cut into 
approximately 2 mm long pieces and submerged in 40 mL of ice-cold PBS with 5 
mM EDTA in a 50 mL Falcon tube. The pieces of tissue in PBS-EDTA were then 
incubated at 37oC with gentle rocking for 30 minutes. Following this incubation, 
colonic tissue was vigorously shaken to disperse colonic crypts and surface 
epithelium in solution. Supernatant was then loaded into 1.5 mL microcentrifuge 
tubes and spun at 1x103 g for 5 minutes to pellet suspended cells. Isolated 
epithelial cells were used in downstream applications, such as RT-qPCR and 
Immunoblotting. 
 
RNA Isolation and RT-qPCR analyses. Isolated colonic epithelium were 
resuspended in Qiazol (Qiagen, Valencia, Ca). Total-RNA was isolated using the 
MicroRNEasy kit, as per manufacturer’s instructions (Qiagen, Valencia, Ca). 
Concentrated RNA was immediately quantified using the Nanodrop 1000 
(Thermo, Waltham, MA). RNA was then stored at -80oC until further application. 
Real-time PCR was carried out using a one-step kit that included 10 minutes of 
reverse transcription of total-RNA (50 ng/well) followed immediately by 
quantitative PCR utilizing a dsDNA-binding dye (New England Biolabs, Ipswich, 
MA).  Custom primers (400 nM/primer/well) designed using the NCBI primer-
blast application were utilized to amplify specific targets (Table-1). Determination 
of differential expression was achieved using the 2-ΔΔCt method, (21). β-Actin 
threshold cycles for each sample were obtained and then subtracted from 
threshold cycles of transcripts of interest to obtain a ΔCt value. The ΔCt value 
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from control samples was then subtracted from DSS-colitis samples to obtain a 
ΔΔCt value. Fold changes of transcripts of interest were then calculated as 2-ΔΔCt 
.This method was utilized for comparison of all quantitative PCR values 
presented within the text and figures. 
 
Protein Isolation and Western Blotting.  Pelleted colonic epithelium were 
resuspended in 350 µl of RIPA (radioimunnoprecipitation assay) buffer containing 
full protease inhibitor cocktail (cOmplete, Mini, Sigma-Aldrich, St. Louis, MO). 
Tissue was homogenized using glass homogenizers with a final sonication step 
to fully liberate transmembrane proteins. Protein concentration for each individual 
sample was determined using the Pierce BCA protein quantification kit (Thermo, 
Waltham, MA). Samples were then immediately frozen at -80oC and maintained 
there until further use. On the day of immunoblotting, protein samples were 
removed from the -80oC freezer and allowed to thaw on ice. Samples were 
diluted to 1 µg/µl with the addition of 4x Lammelli buffer (Biorad, Hercules, CA) 
and remaining volume with diH2O. Following preparation, protein samples were 
warmed at 37oC in a water bath for 15 minutes and then loaded at 20 µg/well 
onto handcast tris-glycine gels (SureCast, Invitrogen, Waltham, MA).  Running 
conditions consisted of 85V until passing the stacking buffer at which point the 
gel was completed at 135V. Gels were transferred to PVDF membranes for 90 
minutes at a constant 20V. Upon completion, PVDF membranes were blocked in 
5% non-fat dry milk (Kroger, Cincinnati, OH) in tris-buffered saline with 0.1% 
tween-20 (TBST) for a period of 1 hour at room temperature. PVDF membranes 
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were then incubated in primary antibody: TMEM16A 1:500, CFTR 1:200, BEST2 
1:500, M3R 1:200 (Alomone Labs, Jerusalem, Israel), IP3R 1:500, β-Actin 
1:1000 (Cell Signaling, Danvers, MA) overnight at 4oC. In the morning, 
membranes were washed 5x in TBST for 5 minutes and then placed in goat anti-
rabbit horseradish-peroxidase conjugated secondary antibody (1:10000 dilution) 
for 2 hours at RT. Membranes were washed 5x in TBST and imaged on the G-
Box (Syngene, Cambridge, United Kingdom). All target proteins were quantified 
using the imageJ software (National Institute of Health, Bethesda, MD) with 
normalization to β-Actin. 
Statistics. All presented results represent mean ± standard error (SE) from five 
different animals, unless otherwise denoted. Statistical tests that were performed 
on the presented data sets were either unpaired student’s t-test or one-way 
ANOVA with Tukey post-hoc analysis using GraphPad Prism 6.0 (San Diego, 
CA). p < 0.05 was used for determination of significance. 
 
Stock Solutions. DSS (MP Biomedicals, Burlington, MA) 4% in the drinking 
water. Ussing chamber stock solutions were: 5 mM Indomethacin (Indo, 
dissolved in ethanol; Sigma-Aldrich, St. Louis, MO), 1 mM Tetrodotoxin (TTX, 
dissolved in acetic acid; Tocris Pharmaceuticals, Minneapolis, MN), 10 mM 
Amiloride (Amil, dissolved in DMSO; Sigma-Aldrich, St. Louis, MO), 100 mM 
Carbochol (CCH, dissolved in deionized water; Sigma-Aldrich, St. Louis, MO), 10 
mM Forskolin (FSK, dissolved in DMSO; Tocris Pharmaceuticals, Minneapolis, 
MN), and 3 µM Ionomycin (IONO, dissolved in DMSO; Tocris Pharmaceuticals, 
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Induction of Chronic DSS-colitis in Balb/c mice. Model accuracy was 
evaluated using several parameters previously utilized to demonstrate consistent 
induction of DSS-colitis (19). Colon length in the DSS-colitis group exhibited a 
consistent shortening as compared to control mice (Fig. 1A). Group data of 
measured colonic lengths from control mice were significantly longer than their 
DSS counterparts (8.75 ± 0.276 cm vs. 6.05 ± 0.221 cm, p < 0.001) (Fig. 1B). 
Histological studies were also conducted to examine proper colitis induction. The 
whole thickness of tissue isolated from control mice exhibited normal histological 
architecture (i.e. stacked test tubes) with intact surface epithelium and minimal 
inflammatory cells located in the lamina propria (Fig. 1C, top). Colonic mucosa 
from DSS-colitis animals exhibited substantial widening of the lamina propria as 
a result of an influx of inflammatory cells (Fig. 1C, bottom). Crypts in the colitic 
colon were also distorted with an obvious enlargement of the underlying 
muscularis (Fig. 1C, bottom), which could be the result of increased proliferation. 
However, this could also be the result of colonic contraction and without a marker 
for proliferation cannot be excluded. Transcript abundance of acute-phase 
reactants was quantitated to further demonstrate active inflammation within the 
distal colon. Quantitative PCR (qPCR) demonstrated a significant increase in 
cytokine transcript abundance of TNFα (1.008 ± 0.033 vs. 8.293 ± 0.732, p < 
0.0001) and IL-6  (0.980 ± 0.017 vs. 10.530 ± 1.045, p < 0.0001) from DSS-colitis 
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samples (Fig. 1D). Besides the prototypical inflammatory cytokines, Th2-
mediated cytokines were selected for study for their relevance to the clinical 
pathology, UC. IL-17 mRNA abundance was not significantly increased (1.000 ± 
0.754 vs. 2.964 ± 0.676), however, transcript abundance of IL-4 (1.506 ± 0.747 
vs. 7.109 ± 2.229, p < 0.05), IL-10 (1.062 ± 0.144 vs. 11.310 ± 2.262, p < 0.01), 
and IL-33 (0.998 ± 0.028 vs. 4.340 ± 1.367, p < 0.05) were all significantly 
increased in the DSS-colitis mice (Fig. 1D).  
Effect of Chronic DSS-induced Colitis on Ca2+-activated Cl- Secretion. 
Control mucosa demonstrated a robust increase in Ca2+-activated Cl- secretion, 
which was measured as positive deflections in short-circuit current (ISC) (ΔISC, 
15.40 ± 2.22 µA/cm2, n = 5) (Fig. 2F). This was paralleled by a calculated 
hyperpolarization of transepithelial potential (ΔVTE, -1.64 ± 0.21 mV, n=5) (Fig. 
2E) following 100 µM CCH application (Fig. 2A/C). DSS-treated mucosa did elicit 
a response upon application of CCH, however, this response was significantly 
smaller in magnitude and opposite in apparent charge (Fig. 2B/D). The decrease 
in measured ISC  (ΔISC, -2.47 ± 0.25 µA/cm2, n=5) (Fig. 2F) most likely indicates 
activation of Ca2+-activated K+ channels, which are known to reside in the apical 
membrane of colonic epithelium (31, 32, 36, 42). This altered response to 
basolateral CCH could potentially be related to decreased synthesis of 
prostaglandin E2, which has previously been shown to uncouple CCH-
administration from apical Cl- secretion (7). Also, calculated VTE paralleled this 
response with a slight depolarization due to increased positive charge 
accumulating on the luminal side of the chamber (ΔVTE, 0.296 ± 0.07 mV, n = 5) 
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(Fig. 2E). Application of basolateral 10 µM Forskolin (FSK) was administered to 
assess the tissues ability to respond to another physiological agonist (Fig. 2C/D). 
 
Effect of Acute DSS-induced Colitis on Ca2+-activated Cl- Secretion. 
Following our initial observations in the Ussing chamber that recapitulated 
previously published work with the acute model of DSS, along with western blot 
quantification of TMEM16A that demonstrated a decrease in expression (1.000 ± 
0.13 vs. 0.065 ± 0.01, p < 0.05), we decided to utilize the acute model (16, 19). 
This was done to establish that changes in CCH-induced ISC were in fact due to 
aberrations in intracellular Ca2+ responses. However, we first needed to establish 
that our acute model of DSS-induced colitis was in agreement with previously 
published literature (16). As previously seen with our controls from the chronic 
model, control mucosa elicited a robust increase in ISC (ΔISC, 29.42 ± 6.42 
µA/cm2, n = 6) when exposed to basolateral 100 µM CCH (Fig. 3A/C). Also as 
expected, colonic mucosa isolated from animals that received DSS demonstrated 
a drop in baseline ISC (ΔISC, -2.43 ± 0.17 µA/cm2, n = 6) following basolateral 100 
µM CCH (Fig. 3B/C). To then establish that Ca2+ mediates the CCH-induced 
changes in ISC in control and DSS mucosa, 3 µM ionomycin (calcium ionophore, 
IONO) was added prior to basolateral CCH administration. 3 µM IONO induced 
an increase in measured ISC in control mucosa (ΔISC, 15.30 ± 2.24 µA/cm2, n = 4) 
(Fig. 3D/E), which was followed by basolateral addition of 100 µM CCH. 
Administration of CCH was only able to minimally increase ISC (ΔISC, 0.90 ± 1.09 
µA/cm2, n = 4) (Fig. 3D/E). And when compared to mucosa that was treated with 
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CCH prior to IONO, the measured increase in ISC was significantly less (ΔISC, 
29.42 ± 6.42 µA/cm2 vs. 0.90 ± 1.09 µA/cm2, p< 0.01) (Fig. 3F).  Colonic mucosa 
from DSS-colitis mice was then incubated with 3 µM IONO, which caused a drop 
in baseline ISC (ΔISC, -3.21 ± 0.73 µA/cm2, n = 4) (Fig. 3G/H). Following this, 100 
µM CCH was administered to the basolateral surface of the tissue. CCH was only 
able to elicit a small drop in measured ISC (ΔISC, -0.31 ± 0.49 µA/cm2, n = 4) (Fig. 
3G/H). Overall, this demonstrated a similar pattern to control mucosa of CCH-
induced ISC being attenuated when following IONO administration (ΔISC,  -3.21 ± 
0.73 µA/cm2 vs.    -0.31 ± 0.49 µA/cm2, p< 0.01) (Fig. 3I). Taken together, these 
results would indicate that CCH-induced changes ISC are Ca2+-mediated in both 
control and DSS-exposed mucosa. 
 
Effect of Chronic DSS-induced Colitis on Cl- Channel Transcript 
Abundance.  RT-qPCR analysis was utilized to assess transcript abundance of 
several Cl- channels known to be expressed in distal colonic epithelium (28, 37, 
41). Two Ca2+-activated Cl- channels (Tmem16a, Best2) as well as the cystic 
fibrosis transmembrane regulator (Cftr) were selected for analysis. Tmem16a 
mRNA abundance was significantly decreased in epithelium isolated from DSS-
colitis mice (1.045 ± 0.15 vs 0.325 ± 0.04, p < 0.01) (Fig. 4A), which may indicate 
a potential decrease in translated channel protein. However, Best2 (0.993 ± 0.03 
vs. 0.301 ± 0.32, p < 0.001) and Cftr (1.042 ± 0.209 vs. 0.096 ± 0.013, p < 0.01) 
were also significantly decreased as compared to control animals (Fig. 4B/C).  
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Effect of Chronic DSS-induced Colitis on Cl- Channel Protein Expression in 
Mucosal Lysates. Western blot of epithelial lysates focused on different Cl- 
channels implicated to elicit a response to increasing intracellular levels of Ca2+ 
in colonic epithelium. Western blot technique was carried out on lysates to 
assess potential differences in protein expression between control and DSS 
mice. As previously seen with the RT-qPCR data, TMEM16A was significantly 
down-regulated in DSS-colitis (1.001 ± 0.13 vs. 0.510 ± 0.12, p < 0.05) (Fig. 
5A/B). However, western blot quantification of BEST2, another CaCC, from the 
lysates demonstrated no difference between control and DSS groups (0.952 
±0.04 vs. 0.930 ± 0.031, p > 0.05) (Fig. 5A/C). CFTR was also quantified via 
western blot technique. This was to address previous observations that have 
described a mechanism by which CFTR is Ca2+-sensitive (5, 38). Protein 
expression for CFTR was also unaltered (1.074 ± 0.09 vs. 1.053 ± 0.07, p > 0.05) 
(Fig. 5A/D) despite the mRNA transcript abundance being significantly 
decreased, similar to Best2 (Fig. 4B/C). 
 
Transcript and Protein Abundance of Gαq Muscarinic Signaling Pathway. 
Previous work has shown that the decreased CCH-stimulated ISC in DSS-colitis 
was attributable to aberrations in signaling of pro-secretory stimuli (1, 18). To 
assess this from the standpoint of activation by CCH, mRNA abundance, as well 
as protein expression, of the M3 receptor (CHRM3), a prototypical Gαq G-protein 
coupled receptor, was quantified in the distal colon. mRNA transcript abundance 
for Chrm3 was unchanged between control and DSS-colitis groups (1.028 ± 0.12 
vs. 1.029 ± 0.27, p > 0.05) (Fig. 6A). Western blot quantification of CHRM3 was 
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also unchanged between the different experimental groups (1.021 ± 0.24 vs. 
0.928 ± 0.09, p > 0.05) (Fig. 6B/C). While signal transduction is initiated through 
CHRM3, canonical Gαq signaling also includes the production of the second 
messenger inositol triphosphate (IP3), which leads to the release of Ca2+ via 
binding to the inositol triphosphate receptor (ITPR3). While Itpr3 transcript 
abundance was not significantly decreased (0.988 ± 0.09 vs. 0.816 ± 0.05, p > 
0.05), protein expression of ITPR3 was significantly down-regulated (1.000 ± 
0.09 vs. 0.426 ± 0.13, p < 0.01) in DSS-colitis mice as compared to their parallel 
controls (Fig. 6A, B, D). 
 
Immunohistochemistry of TMEM16A in Distal Colon of Control and DSS 
Mice. Immunohistochemistry (IHC) of TMEM16A was performed to follow-up the 
finding of decreased protein expression with immunoblotting (Fig. 5A/B) and to 
determine the exact localization of that protein. IHC performed with anti-
TMEM16A antibody on control tissue demonstrated staining of the surface 
epithelium with additional staining of the upper crypts (Fig. 7A). However, DSS-
exposed tissue that was incubated with anti-TMEM16A antibody demonstrated 
substantially less membrane staining of the epithelium, with more generalized 
staining of the cytoplasm (Fig. 7C). This generalized staining, especially in DSS-
colitis, is most likely sub-apical vesicles that have not been properly trafficked to 
the plasma membrane, however, the staining could also be potential splice 
variants of TMEM16A located in cellular organelles. Control peptide experiments 
incubated with the anti-TMEM16A antibody were run in parallel for both groups. 
The addition of peptide to either Control or DSS-colitis tissue was devoid of 
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staining indicating specificity of the antibody, instead of possible non-specific 





Utilizing the previously described model of colitis in mice (20, 39), five 
alternating weeks of 4% DSS administration was able to induce epithelial 
dysplasia, crypt distortion and increased inflammatory infiltrate in the lamina 
propria, similar to the histopathological features observed in UC (2). Previously, 
acute induction of DSS-colitis had resulted in decreased CCH-stimulated Ca2+-
activated Cl- secretion in murine distal colon (3, 16). However, these losses in 
Ca2+-activated Cl- secretion have been attributed to dysfunctional muscarinic 
receptor signaling (1), or membrane depolarization related to decreased 
functioning of basolateral K+ channels (16). These previous works were also 
conducted prior to the discovery of the novel CaCC, TMEM16A (6, 34, 40). 
TMEM16A exhibits a similar electrophysiological profile to that found in cultured 
and native human bronchial epithelium (6). Also, global and tissue-specific 
knockout studies of TMEM16A in mice have demonstrated an absence of Ca2+-
activated Cl- secretion (4, 28).  
In this study, our findings demonstrate a significant attenuation in Ca2+-
activated Cl- secretion in the colitic colon that is in part due to the down-
regulation of TMEM16A. This conclusion is evidenced by the use of a Ca2+ 
ionophore (ionomycin) that demonstrates a complete lack of Ca2+-activated Cl- 
secretion (Fig. 3), as well as significantly decreased mRNA abundance and 
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protein expression of TMEM16A in the DSS-induced colitic colon (Figs. 4 & 5). In 
addition, other potential canonical and non-canonical CaCCs were also 
examined (5, 41). Transcript abundance was decreased for both Best2 and Cftr 
(Fig. 4), however, the protein expression of these Cl- channels in whole cell 
lysates was unchanged in the colitic colon, as compared to control littermates 
(Fig. 5). Also, transcript abundance and protein expression of CHRM3 were 
unchanged in DSS-induced colitis (Fig. 6), which is in agreement with a more 
recent publication (16). Taken together, our results indicate that decreased 
expression of TMEM16A following DSS administration substantially blunts Ca2+-
activated Cl- secretion in murine distal colon. 
While TMEM16A expression was substantially down-regulated, the protein 
expression of ITPR3 was also significantly decreased in the DSS-colitis cohort 
(Fig. 6). And while this could contribute to the attenuation in CCH-stimulated Cl- 
secretion in DSS-colitis, a previous observation with a tissue-specific knockout of 
TMEM16A in colonic epithelium demonstrated decreased CCH-stimulated Ca2+ 
release as measured by fura-2 (33). Schreiber et al. did put forth one possibility 
that TMEM16A may provide a physical tether for ITPR3 to the plasma membrane 
and loss of TMEM16A could disrupt this architecture (33). Also, a prior study has 
demonstrated a physical interaction of TMEM16A and ITPR3 in nociceptive 
neurons (17). Taken together with our findings, the diminished expression of 
TMEM16A in colonic epithelium could cause a destabilization of ITPR3 in 
endoplasmic reticular membranes, leading to a premature degradation of the 
receptor. This notion is supported by the fact that mRNA abundance of Itpr3 
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(0.988 ± 0.09 vs. 0.816 ± 0.05, p > 0.05) is not significantly decreased in DSS-
colitis (Fig. 6). This would potentially indicate a non-genomic mechanism of 
decreased protein expression, possibly a protein-protein interaction between 
ITPR3 and TMEM16A.  
Though it is most likely that the down-regulation of TMEM16A is a result of 
transcriptional regulation, it is uncertain as to what mechanism mediates this 
regulation of the channel. Several groups have previously shown that IL-4 and IL-
13, Th2 immune mediators, were able to significantly increase Ca2+-activated Cl- 
secretion in bronchial epithelium (6, 43).  Another group incubated IL-4 and IL-13 
on immortalized colonic epithelium (T84), and while IL-13 did not seem to have an 
effect, IL-4 was able to substantially inhibit the CCH-stimulated ISC in a dose-
dependent manner (23). Another study incubated IL-10 on T84 monolayers and 
was able to demonstrate a similar dose-dependent inhibition of CCH-stimulated 
ISC (24). Together, this would provide support that Th2 signaling in colonic 
epithelium may oppose the effects that are observed in respiratory epithelium. 
Also, it is worth noting that our results demonstrate a significant increase in 
transcript abundance of several prototypical Th2 cytokines (Fig. 1D), which could 
lead to the decreased expression of TMEM16A.  
Previous studies have demonstrated the importance for TMEM16A in 
mucociliary clearance in murine airways (28, 30). Furthermore, poor hydration of 
the mucus layer between secretory epithelium and resident bacteria has been 
shown to promote an environment of bacterial overgrowth, leading to an 
increased interaction of non-host with host (25, 27). This potentially highlights the 
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impact that TMEM16A may have on colonic inflammation in UC. Utilizing these 
previous observations, we speculate that decreased TMEM16A may exacerbate 
colonic inflammation via an increase in interaction between resident immune 
cells and the microbiota. From a clinical perspective an increase in Ca2+-activated 
Cl- secretion could decrease this interaction and help to ameliorate further 
inflammation induced via this mechanism.  
In conclusion, our findings demonstrate a significant decrease in Ca2+-
activated Cl- secretion in a DSS-induced colitic colon. The CaCC, TMEM16A, is 
significantly decreased in the DSS-induced colitis cohort of mice, while other Cl- 
channels (BEST2, CFTR) were unchanged at the protein level. The significant 
decrease in ITPR3 may be the result of a loss of TMEM16A stabilization through 
protein-protein interactions. Also, we speculate that the loss of TMEM16A in 
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Figure 1. Evaluation of DSS-colitis in Balb/C Mice. A. Representative images 
of excised colons from either control or DSS-colitis cohorts. B. Group data of 
measured colons from either control or colitic mice. Represented data is means ± 
SE of different groups, collected from 6 different animals in each respective 
group (p < 0.001). C. Haemotoxylin and eosin staining of formalin-fixed colonic 
tissue. Each image represents a different animal from their corresponding 
treatment. DSS-colitis (C, Bottom) demonstrates crypt dysplasia, leukocyte 
infiltration, and thickening of underlying serosa (20x, AxioImager). D. RT-qPCR 
analyses of multiple cytokines involved in the development of colitis. Asterisks (*) 
indicate significance of each individual cytokine transcript as compared to 
control. *p < 0.0001 – compared to control; $p < 0.01 – compared to control; #p < 
0.05 – compared to control. 
 
Figure 2. Effect of DSS-colitis on transepithelial potential and Cl- secretion. 
A. Representative trace of calculated transepithelial potential (VTE) in control 
mice following application of 100 µM carbochol (CCH) and 10 µM Forskolin 
(FSK). B. Representative trace of calculated VTE in DSS-colitis mice following 
application of 100 µM CCH and 10 µM FSK. C. Representative trace of elicited 
short-circuit current (ISC) in control mice following basolateral administration of 
100 µM CCH and 10 µM FSK. D. Representative trace of elicited ISC in DSS-
colitis mice following basolateral administration of 100 µM CCH and 10 µM FSK. 
E. Summarized data of calculated ΔVTE following CCH administration in either 
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control (open bars) or DSS-colitis (closed bars) mice. DSS-colitis demonstrates a 
complete inhibition with an actual reversal in polarity as compared to control. F. 
Group data of ΔISC from both control (open bars) and DSS-colitis (closed bars) 
groups following CCH-administration. DSS-colitis, in parallel to calculated ΔVTE, 
demonstrates an elicited current that is in opposition to that of the control cohort. 
Bar graphs of summarized data represent means ± SE of 5 different animals. *p 
< 0.001 - compared to control.  
 
Figure 3. Effect of Ionomycin on CCH-induced Changes in ISC from Control 
and Acute DSS-Colitis Mice. A. Representative trace of measured short-circuit 
current (ISC) following basolateral 100 µM carbochol (CCH) administration to 
control mucosa. B. Representative trace of ISC from DSS-colitis mucosa following 
basolateral 100 µM CCH administration. C. Group data of ΔISC following CCH-
administration in control and DSS mice. D. Representative trace of ISC from 
control mucosa that was stimulated with 3 µM ionomycin (IONO) and followed by 
100 µM CCH. E. Group Data of ΔISC with 3 µM IONO followed by 100 µM CCH in 
control mucosa. F. Group data of CCH-induced ΔISC with and without 3 µM IONO 
administration. G. Representative trace of ISC from mucosa exposed to DSS 
administered 3 µM IONO and 100 µM CCH. H. Group data of ΔISC from DSS-
colitis in response to 3 µM IONO followed by 100 µM CCH administration. I. 
Group data of DSS-colitis CCH-induced ΔISC with and without 3 µM IONO 
administration. All presented bar graphs are summarized data that represent the 
means ± SE. *p < 0.01 – compared to control. 
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Figure 4. Effect of DSS-colitis on transcript abundance of Cl- channels in 
murine colon. Transcript abundance was determined for (A) Tmem16a, (B) 
Best2, and (C) Cftr in control (open bar) or DSS-colitis mice (closed bar). Bar 
graphs of summarized data represent means ± SE of 5 different animals 
normalized to an endogenous control, Actb. *p < 0.001 - compared to their 
respective control. 
 
Figure 5. Effect of DSS-colitis on Cl- channel protein expression in murine 
colon. A. Representative images of protein expression of the different 
characterized Cl- channels from epithelial lysates. B. TMEM16A protein 
expression normalized to β-actin for quantification of control and DSS-colitis 
groups. TMEM16A expression (closed bars) is significantly decreased in DSS-
colitis mice as compared to control. C,D. Summarized data of western blot 
quantification of BEST2 and CFTR normalized to β-actin in control and DSS-
colitis mice. Neither protein was significantly altered from the control cohort. Bar 
graphs of summarized data represent means ± SE of 5 different animals from 
each respective group. *p < 0.05-compared their respective control. 
 
Figure 6. Characterization of Gαq muscarinic signaling pathway. A. 
Transcript abundance of Chrm3 and Itpr3 from control and DSS-colitis groups. 
mRNA abundance of either transcript was not significantly different from the 
control cohort (P>0.05). B. Representative images of western blots for CHRM3 
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and ITPR3 with corresponding loading controls for normalization. C. Summarized 
data of CHRM3 protein expression normalized to β-actin. CHRM3 expression in 
DSS-colitis was unaltered as compared to control counterparts. D. Group data of 
ITPR3 protein expression normalized to β-actin from control and DSS-colitis. 
ITPR3 expression was significantly down-regulated in DSS-colitis. Bar graphs of 
summarized data represent means ± SE of 5 different animals from each 
respective group. *p < 0.01-as compared to control. 
 
Figure 7. Immunohistochemistry of TMEM16A in colonic tissue sections. A. 
Immunohistochemistry of TMEM16A in control tissue demonstrates pronounced 
expression and localization of the protein to surface epithelium and upper crypts 
(top, left). B. DSS-colitis tissue stained for TMEM16A exhibits less staining in 
epithelial cells and a more diffuse signal in the lamnia propria (Bottom, left). C,D. 
Both cohorts of tissue were run in parallel with a control peptide specific for the 
anti-TMEM16A antibody. Both images demonstrate a lack of staining when co-
incubated with control peptide. Images were captured at 20x magnification on the 


















































143 F: 60.32 
R: 59.58 
Table 1. Custom qPCR primers for determination of transcript abundance. 
All primers were designed utilizing the NCBI primer-blast application with the 
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Abstract. The Enteric nervous system (ENS) regulates blood flow, motility and 
electrolyte transport along the entire gastrointestinal tract. KCNQ K+ channels 
have been characterized to contribute to the resting membrane potential in 
visceral neurons and are also present in the ENS. In this study, we wanted to 
evaluate the efficacy of KCNQ activators on the ENS from the standpoint of 
anion secretion in mouse distal colon. Anion (i.e. Cl-) secretion was measured as 
a function of short circuit current (Isc) in intact mouse distal colon mounted under 
voltage clamp conditions in an Ussing chamber. Pharmacological approaches 
were utilized to assess the effect of activation of KCNQ channels in enteric 
neurons on apical Cl- secretion. Immunofluorescence studies were conducted to 
identify the isoform and location specific expression of KCNQ channels. 
Immunofluorescence studies indicated the presence of KV7.2 and KV7.3 channels 
that co-localized with choline acetyl transferase in enteric neurons of mouse 
distal colon. Flupirtine, a KCNQ activator markedly inhibited ISC (i.e. Cl- 
secretion). However, application of flupirtine following tetrodotoxin resulted in a 
significantly blunted response. A similar effect was observed when tissue was 
pre-incubated with the muscarinic antagonist tolterodine. Serosal nicotine 
stimulated Cl- secretion in control colon. However, tissues that were pretreated 
with flupirtine prior to application of nicotine remained unresponsive to the 
ganglionic agonist. Our data indicate that activation of KCNQ (KV7) channels of 
enteric neurons inhibits Cl- secretion. Also, activators of KCNQ channels could 




The enteric nervous system (ENS) is comprised of approximately 400-600 
million neurons [1]. The ENS participates in a multitude of functions that include 
regulation of motility, local control of blood flow during digestion, and influence 
over electrolyte transport [2-5].   
Numerous pathologies have been identified that cause a dysregulation of 
one or all of the previously mentioned regulatory processes [6-8]. While 
Hirschprung’s disease is the most notable of ENS pathologies, and results in an 
absolute loss of enteric neurons, several diseases have been identified that elicit 
an overall hyperexcitable ENS [9, 10]. For example, patients with irritable bowel 
syndrome with diarrhea (IBS-D) administered alosetron demonstrated delayed 
colonic transit times, indicating increased serotonergic signaling and ENS 
overactivity [9]. While IBS-D is considered more of a disease of the developed 
world, infections with rotavirus or vibrio cholera can also cause excitation of 
enteric neurons, which could increase epithelial secretion and contribute to the 
overall pathology of each of those diseases [8, 11].  
K+ channels are responsible for setting the resting membrane potential in 
a vast array of cells due to the large permeability of K+ as compared to other 
predominant ions [12]. The KCNQ (KV7) family, which are voltage-sensitive K+ 
channels (KV), have been described to regulate resting membrane potential in 
several different cell types [13-15]. The KV7 family has been described as small, 
slow-deactivating K+ channels with a hyperpolarized threshold for half-maximal 
activation [16]. A couple members of the KV7 family, KV7.2 and KV7.3, have been 
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characterized as making up the native M current, and more importantly 
contributing to resting membrane potential in neurons [17-20]. Disruptions in 
these genes have led to the development of seizures and hyperalgesia in rodent 
models [19, 21, 22].  Previous observations have also shown KV7.3 to co-
immunolocalize with sensory afferents in the gastrointestinal tract, as well as, 
participate in visceral nociception [18, 23].  
While the KV7 family has been shown to be present in neurons located 
within the gastrointestinal tract, it has not previously been studied from the 
aspect of epithelial electrolyte transport. Therefore, the goal of this study was to 
evaluate the efficacy of KV7 activators on enteric neurons and the resultant effect 
on mucosal electrolyte transport. Our results indicate that KV7.2/3 activation 
causes an immediate and sustained hyperpolarization of enteric neurons that 





















Material and Methods 
 
Animals. Male Balb/c mice (10-13 weeks, Charles River, NY) were provided 
normal chow and water ad libitium for the entirety of the project. All animals were 
anesthetized via 5% inhalational isoflurane (Patterson Veterinary, SC) for 
isolation of the whole colon for downstream applications. Mice were then 
euthanized via cervical dislocation. All experimental protocols utilized in this 
study were approved by the West Virginia University Institutional Animal Care 
and Use Committee.  
 
Cell Culture. The colonic adenocarcinoma T84 cell line (ATCC, Manassas, VA) 
was maintained and passaged in a T75 flask (Corning, Corning, NY) that was 
kept at 37oC and 5% CO2- 95% O2 gas. Cells were maintained in DMEM/F12 
(ThermoFisher, Waltham, MA) supplemented with 10% fetal bovine serum (FBS) 
(Fisher Scientific, Hampton, NH) with 1% pencillin-streptomycin (Mediatech, 
Manassas, VA). Upon passage, cells were seeded close to confluence on 1.12 
cm2 transwell plates (Corning, Corning, NY) for use in Ussing chamber 
monolayer studies. T84 cells maintained on the transwell plates were checked for 
confluence each day. Upon reaching confluence, cells were then maintained in 
monolayers for 18 days for proper development of tight junctions, as well as, 
differentiation of the colonic epithelial cell line. Media was replaced every other 





Native tissue. Whole colon was removed from the anesthetized mouse and 
rinsed with ice-cold phosphate-buffered saline (PBS) to remove any residual 
contents. Whole colon was then pinned near the caecum in a sylgard plate filled 
with ice-cold PBS containing 5 µM indomethacin. The colon was then opened 
longitudinally along the mesenteric border of the tissue. The sylgard dish was 
then placed under a dissecting microscope for the isolation of distal colon 
segments. Whole-mount distal colon was then placed on an oval 0.04 cm2 
aperture for mounting in the EasyMount Ussing chamber (Physiological 
Instruments, San Diego, CA) for electrophysiological study, as previously 
described [24]. Mounted tissue was then bathed with bilateral addition of 5 mL of 
Ringers’ physiological saline solution (in mM: 115 NaCl, 25 NaHCO3, 2.4 
K2HPO4, 0.4 KH2PO4, 3 KCl, 1.2 CaCl2, 1.2 MgCl2 and 10 glucose) to each hemi-
chamber. Tissues were allowed to equilibrate in open-circuit conditions for a 
period of 15 minutes prior to voltage-clamping. All mounted tissues were 
continuously voltage-clamped at 0 mV to abolish any developing electrical 
gradient. Short-circuit current (Isc) was continuously monitored with a 5 mV pulse 
applied every 5 seconds to determine transepithelial resistance. Tissues were 
maintained in the chamber at 37oC and continuously gassed with 5% CO2- 95% 
O2 (pH 7.4).  
T84 monolayers. The day of experiments, PBS was warmed in a water bath to 
37oC for washing of T84 monolayers maintained on transwell plates. Inserts of T84 
cells were removed from their respective plates and gently washed with warmed 
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PBS until clear. Monolayers were then mounted in the EasyMount Ussing 
chamber and bathed on both sides by Ringers’ physiological saline solution. 
Monolayers were voltage-clamped at 0 mV for the duration of the experiment 
with a 5 mV pulse applied every 5 seconds. However, all monolayers were 
allowed to equilibrate and come to a steady-state prior to the application of any 
drugs.  
All representative traces presented within this article are designated as positive 
ISC indicating either secretion of an anion or absorption of a cation from the 
mucosal surface, while negative deflections of ISC indicate cation secretion or 
anion absorption from the mucosal side of the tissue. 
 
Immunofluorescence. Whole colon was removed from euthanized mice and 
rinsed with ice-cold PBS to remove any residual contents. Tissues were pinned 
on a sylgard plate and opened longitudinally along the mesenteric border. Colon 
was then pinned along the borders with the mucosa facing up. A shallow, 
longitudinal cut was made to remove mucosa from the underlying myenteric 
plexus and smooth muscle. Mucosa was then carefully teased away, starting 
from the cut and moving proximally along the colon. Upon isolation of the 
myenteric plexus and longitudinal smooth muscle, tissues were placed in 10% 
neutral-buffered formalin for 2 hours at RT. Following fixation, tissue was placed 
in 30% sucrose solution dissolved in PBS and stored at 4oC until further 
processing. The day of immunostaining, tissue was removed from sucrose 
solution and washed 3x with PBS for a period of 1 hour to rehydrate the tissue. 
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Tissue was then incubated with 1% Triton-X100 PBS for a period of 4 hours to 
fully permeabilize the membranes. Samples were then washed with PBS 3x for 
10 minutes and placed in 5% goat serum to block for 2 hours. Following blocking, 
tissue was placed in the different primary antibodies (KV7.2 1:100, KV7.3 1:100, 
Alomone Labs, Jerusaleum, Israel, ChAT 1:100 Millipore, Burlington, MA ) diluted 
in blocking solution overnight at 4oC with gentle shaking. In the morning, tissue 
was washed with PBS at RT 5x for 5 minutes. Upon completion of washing, 
tissue was incubated with secondary antibody (anti-rabbit Alexa Fluor 488 1:500, 
anti-goat Alexa Fluor 546 1:500) for 4 hours in the dark at RT. Tissue was 
removed and washed with PBS 5x for 5 mins to dilute out any residual secondary 
antibody. Samples were then mounted on slides with mounting media (Slowfade 
Diamond, ThermoFisher, Waltham, MA) and imaged for immunolocalization 
accordingly. All images were captured on LSM 510 confocal microscope (Carl 
Zeiss, Oberkochen, Germany) with a 63x oil-immersion objective.   
 
Percent Inhibition and Dose-Response.  
Percent inhibition. The percent inhibition of the different drugs was calculated by 
obtaining the maximal response from all applied agents and then dividing the 
measured change in ISC by the maximal response to obtain a percent value. Data 
was transformed into a percent due to variability in baseline measurements 
between mounted tissues. Percent inhibition was calculated as follows: 
 
Maximal response: Xbaseline Isc-Yremaining Isc 
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Percent Inhibition: (XIsc prior to drug application-Ysteady-state Isc after drug application) 
Maximal response 
 
Dose-Response. This was performed to calculate a half-maximal inhibitory 
concentration (IC50) for flupirtine (general Kv7 agonist) and ICA 110381 (specific 
agonist of Kv7.2/3). Pharmacological agents were diluted from their respective 
stock concentrations to a range of 10-4 M to 10-1 M, which were then diluted 
1:1000 (5 µL into 5 mL) within the chamber. Different concentrations were added 
sequentially, starting with 10-4 M and increasing by a factor of 10 for each 
addition. Tissue was allowed to reach a steady-state prior to the application of 
the next administered dose.  
 
Statistics. All presented data represent mean ± standard error (sem) from five 
different animals, unless otherwise denoted within the text. Statistical tests that 
were performed on the presented data was student’s unpaired t-test using 
Graphpad Prism 5.0 (San Diego, CA). p < 0.001 was used for the determination 
of significance.    
 
Stock solutions. Indomethacin was prepared as a 5 mM stock solution in 
ethanol. Ussing chamber stocks are as follows: 1 mM tetrodotoxin (TTX, 
dissolved in acetic acid, Tocris Pharmaceuticals, Minneapolis, MN), 10 mM 
tolterodine (TOL, dissolved in H2O, Tocris Pharmaceuticals, Minneapolis, MN), 
50 mM flupirtine (FLU, dissolved in DMSO, Tocris Pharmaceuticals, Minneapolis, 
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MN), 50 mM ICA 110381 (ICA, dissolved in DMSO, Tocris Pharmaceuticals, 
Minneapolis, MN), 50 mM nicotine (NICO, dissolved in H2O, Tocris 
Pharmaceuticals, Minneapolis, MN), 10 mM forskolin (FSK, dissolved in DMSO, 
Tocris Pharmaceuticals, Minneapolis, MN), and 50 mM XE-991 (dissolved in 
H2O, Tocris Pharmaceuticals, Minneapolis, MN).  
 
Results 
Inhibition of ISC in Whole-Mount Colon with the Kv7 Activator Flupirtine. 
Previous studies have shown that inhibition of the ENS with tetrodotoxin (TTX), a 
voltage-sensitive Na+ channel (NaV) inhibitor, was able to significantly attenuate 
the on-going basal Cl- secretion in Ussing chambers [25]. This is accomplished 
via inhibiting propagation of action potentials and eventual release of 
neurotransmitters [26]. With this in mind, flupirtine, a Kv7 activator that 
hyperpolarizes neurons and ultimately decreases release of neurotransmitter, 
could be applied to indirectly inhibit on-going Cl- secretion. As demonstrated by 
the representative trace (Fig. 1A), basolateral 100 µM flupirtine application was 
able to significantly decrease the observed ISC from the mounted tissue. 
However, basolateral application of 1 µM TTX only slightly decreased ISC (Fig. 
1A). Group data of 100 µM flupirtine application prior to 1 µM TTX administration 
demonstrated a similar pattern of flupirtine being responsible for a significant 
majority of the percent of inhibited ISC (FLU vs. TTX, 94.23 ± 1.50 % vs. 5.77 ± 
1.50 %) (Fig. 1C). However, administration of 1 µM TTX prior to flupirtine resulted 
in a significant decrease in measured ISC, while flupirtine only slightly decreased 
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ISC (Fig. 1B). Group data of TTX administration prior to flupirtine also 
demonstrated a similar pattern with TTX conferring a majority of the percent-
inhibited ISC in Ussing chamber experiments (TTX vs. FLU, 77.92 ± 6.6 % vs. 
22.08 ± 6.6 %, p< 0.001) (Fig.1D). Comparison of order of administration 
demonstrated flupirtine following TTX application was significantly less than 
when administered prior to TTX (22.08 ± 6.58 % vs. 94.23 ± 1.50 %, Fig. 1E). 
 
Dose-Response of ISC to Basolateral Flupirtine Application. Following the 
initial finding of flupirtine decreasing ISC in colonic epithelium, we decided to more 
fully characterize the drug by determining a half-maximal inhibitory concentration 
(IC50). Initial administration of 100 nM flupirtine was unable to elicit any effect on 
the tissue, as demonstrated by the representative trace (Fig. 2A). However, 
increasing doses of flupirtine, from 1 µM up to highest concentration of 100 µM, 
were able to inhibit the on-going ISC (Fig. 2A). The data as a whole demonstrated 
a significant inhibition with the addition of 10 µM flupirtine, which accounted for a 
49.44 ± 5.9 % decrease from the previous baseline current. 100 µM flupirtine 
application was also able to further decrease ISC (37.48 ± 3.8 %), however not as 
robustly as the previously administered 10 µM dose, which would indicate 
reaching an asymptote of effect  (Fig. 2B). Utilizing a non-linear fit to the 
calculated percent of inhibition presented in Fig. 2B, we were able to calculate an 
IC50 for flupirtine of 9.37 ± 0.42 µM.  
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Inhibition of on-going ISC in Colonic Epithelium with the Muscarinic 
Antagonist Tolterodine. As described previously, NaV channels are located 
within ENS neurons, so inhibition of those channels with TTX would inhibit 
neurotransmitter release (i.e. acetylcholine) onto epithelial cells. To further 
establish that basolateral flupirtine may be acting on ENS neurons, we decided to 
use the muscarinic antagonist tolterodine to inhibit acetylcholine activation of 
muscarinic receptors on epithelial cells. As expected and in concordance with 
literature [27], basolateral application of 10 µM tolterodine was able to inhibit a 
significant amount of basal ISC (80.35 ± 3.72 %, Fig. 3C), as illustrated by the 
representative trace (Fig. 3A). Addition of 100 µM flupirtine was able to further 
decrease ISC (19.65 ± 3.72 %, Fig. 3A/C). However, the addition of 100 µM 
flupirtine prior to 10 µM tolterodine application demonstrated a significant 
inhibition of ISC (99.59 ± 0.41 %, Fig. 3B/D), more similar to flupirtine 
administration prior to 1 µM TTX (Fig. 1D). Unexpectedly though, addition of 10 
µM tolterodine to the basolateral surface led to a paradoxical increase in ISC        
(-15.2 ± 8.56 % Fig. 3B/D), as opposed to the decrease in ISC observed with 
flupirtine application. Comparison of order of administration demonstrated that 
flupirtine administration prior to tolterodine resulted in a significant increase in 
percent of inhibition (99.59 ± 0.41 % vs. 19.65 ± 3.72 %, Fig. 3E). 
 
Pre-Incubation with Flupirtine Inhibits Basolaterally-Administered Nicotine-
Induced ISC. Increased firing of ENS neurons has previously been shown to elicit 
increases in measured ISC [4]. In line with this notion, we decided to activate ENS 
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neurons via basolateral addition of 100 µM nicotine. As illustrated by the 
representative trace (Fig. 4A), basolateral administration of nicotine dramatically 
increased measured ISC. Tissue that was pre-incubated with 100 µM flupirtine did 
exhibit the expected decrease in ISC. However, addition of 100 µM nicotine was 
not able to stimulate ISC (Fig. 4B). Tissues that received nicotine-only were able 
to elicit large increases in ISC, while tissues that were pre-incubated with flupirtine 
were practically unresponsive to nicotine (93.22 ± 18.86 µA/cm2 vs. 0.26 ± 1.12 
µA/cm2, Fig. 4C). 
 
Application of Flupirtine and TTX in T84 Monolayers Does Not Inhibit ISC.  
T84 monolayers have been used to study the colonic epithelium for several 
decades [28, 29]. The T84 cell line was originally isolated from a colonic 
adenocarcinoma, and consists of a homogenous population of secretory 
epithelium [30]. Therefore, application of any pharmacological agents that 
interact with ENS neurons to exert their effect would not demonstrate an efficacy 
in the T84 cell line. To establish this within our lab, we first mounted T84 
monolayers in the Ussing chamber, and upon reaching a steady-state applied 1 
µM TTX to the basolateral surface of the monolayer. TTX was without effect (Fig. 
5A/C), however to confirm that monolayers were functioning as a tight epithelium 
10 µM forskolin (FSK) was applied basolaterally. As expected, 10 µM FSK was 
able to increase ISC dramatically (24.58 ± 2.88 µA/cm2, Fig. 5A/D). Following this 
outcome, another group of monolayers were administered 100 µM flupirtine to 
the basolateral side of the chamber. As previously seen with TTX application, 
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100 µM flupirtine was unable to decrease measured ISC, however, there was a 
very modest increase in baseline ISC (0.57 ± 0.23 µA/cm2, Fig. 5B/C). T84 
monolayers were once again administered 10 µM FSK, which significantly 
increased ISC (24.61 ± 4.21 µA/cm2) to comparable levels of T84 monolayers 
exposed to TTX (Fig. 5D). Both groups were then exposed to 50 µM XE-991 
(Kv7 antagonist), which demonstrated a significant inhibition of of FSK-stimulated 
ISC (Fig. 5A/B) 
 
Kv7.2 and KV7.3 Exhibit Co-Localization with Choline Acetyl Transferase in 
ENS Neurons. Since previous work has shown that KV7.2/3 are crucial to the 
native M current in neurons and may contribute to the observed effect of flupirtine 
on ISC, we decided to immuno-label for the two different channels in whole mount 
tissue. Choline acetyl transferase (ChAT) was used as a marker of enteric 
neurons due to the high abundance of cholinergic neurons in the ENS, and 
potential co-localization of the ion channels of interest.  ChAT consistently 
labeled axons of enteric neurons, as illustrated by Fig. 6A/D. KV7.2 and KV7.3 
(Fig. 6B/E) consistently co-localized with enteric neuronal axons that were 
positively immuno-stained for ChAT (Fig. 6C/F).  
 
ICA 110381, a Specific Activator of KV7.2/3, Inhibits ISC in a Dose-Dependent 
Manner. Following identification of KV7.2 and KV7.3 in ENS neurons, we decided 
to use a specific activator of the heterotetramer, KV7.2/3. ICA 110381 has 
previously demonstrated selectivity for KV7.2/3 over the other members of the 
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KCNQ family of K+ channels [31]. Basolateral application of 100 µM ICA was able 
to significantly inhibit the ISC (Fig. 7A). Similar to before with flupirtine, 
administration of 1 µM TTX following ICA was practically unable to decrease ISC 
(Fig. 7A). ICA 110381 was able to account for 96.88 ± 0.94 % of the total 
inhibited ISC, while 1 µM TTX only inhibited 3.12 ± 0.94 % of the current (Fig. 7B). 
A dose-response curve was also generated for ICA 110381 (Fig. 7C). 
Concentrations ranging from 1 µM to 100 µM were able to decrease ISC. The use 
of a non-linear fit of the grouped data allowed for the calculation of an IC50 for 
ICA 110381, which was 10.55 ± 0.75 µM (Fig. 7D).  
 
Discussion 
Our findings in this study indicate that hyperpolarization of enteric neurons 
with the KV7 activator flupirtine is able to decrease resultant mucosal secretion 
via decreased neuronal firing. This conclusion is evidenced by the fact that 
flupirtine administration prior to TTX leads to substantial inhibition of baseline ISC, 
however the simple reversal of that order leads to a significant inhibition of ISC by 
TTX with a much smaller contribution from flupirtine (Fig. 1). As not to rely on this 
as our only evidence, we then characterized the ability of flupirtine to inhibit 
nicotine-stimulated ISC, which is mediated through nicotinic receptors on post-
ganglionic fibers [32]. Control tissue administered basolateral nicotine 
demonstrated a significant increase in ISC, however pre-incubation with flupirtine 
left the tissue practically unresponsive, owing to ENS neurons being substantially 
hyperpolarized (Fig. 4). Also, to more fully implicate the ENS in mediating the 
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effects of flupirtine, T84 monolayers [30] did not exhibit a decrease in ISC upon 
basolateral administration (Fig. 5). We then wanted to try and characterize the 
specific KV7 channels responsible for mediating the effects of flupirtine. 
Immunofluorescence studies demonstrated that the canonical M current 
channels, KV7.2 and KV7.3, co-localized with axons that stained positively for 
ChAT (Fig. 6). Finally, the use of the KV7.2/3 activator, ICA 110381, 
demonstrated a similar profile to flupirtine administration (Fig. 7). In total, our 
results would indicate that the decrease in ISC from basolateral application of 
flupirtine is ENS-mediated via hyperpolarization of enteric neurons through 
activation of KV7.2/3.  
KV7.1, another member of the KV7 family, has been localized and 
functionally described in epithelial tissues [33-35] and could be thought to 
participate in the observed response in native tissue. However, activation of 
KV7.1 in epithelial tissues leads to an increase in K+ recycling via the basolateral 
membrane and an increase in apical Cl- secretion [36]. These previous 
observations would agree with our results that flupirtine was not able to decrease 
ISC in T84 monolayers, but actually resulted in a small increase in ISC [37] from 
activation of presumably of KV7.1 (Fig. 5). To further demonstrate the importance 
of KV7 in apical Cl- secretion, XE-991, a non-specific KV7 inhibitor, was 
administered to the basolateral membrane of T84 monolayers, which 
demonstrated a significant decrease in FSK-mediated ISC.  
The effect of flupirtine on cholinergic neurons was also studied, since 
cholinergic fibers make up approximately 60% of neurons within the ENS [38]. As 
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expected, tolterodine (muscarinic receptor antagonist) application was able to 
partially inhibit on-going mucosal Cl- secretion [39, 40]. Flupirtine was able to 
further decrease measured ISC. This would indicate that non-cholinergic 
neurotransmitters also participate in modulating mucosal electrolyte transport, 
which has also been previously described [25]. Application of flupirtine prior to 
tolterodine would then be expected to inhibit all ENS neurons, and the application 
of the muscarinic receptor antagonist following this would have no effect or only 
very modestly decrease ISC. However, tolterodine application following flupirtine 
administration unexpectedly increased ISC (Fig. 3B/D). This could be the result of 
a subpopulation of interneurons that are less sensitive to flupirtine. Application of 
tolterodine would block the remaining excitatory stimulation on inhibitory 
secretomotor neurons, which would remove the “brake”, and lead to the 
observed increase in ISC.  
Previous studies have shown that several gastrointestinal disorders result 
in an overall increase in excitability of ENS neurons [8-10, 41]. However, current 
clinical options are limited for these pathologies, with many observed adverse 
effects [42, 43]. Unfortunately, flupirtine, which had been available for nearly 
three decades in several European countries, was recently removed from the 
market due to issues of hepatotoxicity [44]. Development of novel KV7 channel 
activators, with a greater safety profile, could yield therapeutic potential in 
patients that have been unresponsive to traditional treatments for an over-active 
ENS. Since KV7 channel activation causes a sustained hyperpolarization of 
enteric neurons that synapse on the epithelium, as well as the smooth muscle, 
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targeted treatment could help to alleviate associated-symptoms. Also, our 
immunofluorescence studies demonstrate localization of KV7.3 in gastrointestinal 
smooth muscle (Fig. 6), which along with previous observations of KV7 channels 
in smooth muscle may further enhance the efficacy of a KV7 activator by reducing 
motility of gastrointestinal tract [45]. In all, KV7 activators could potentially be 
utilized clinically for the treatment of gastrointestinal disorders attributed to hyper-
excitability of the ENS.  
In summary, our results demonstrate that activation of KV7 channels via 
flupirtine in enteric neurons significantly inhibits mucosal electrolyte transport in 
the colon. As demonstrated through immunofluorescence studies and a specific 
pharmacological activator, this mechanism is mediated through KV7.2/3 located 
within axons of enteric neurons. Also, this discovery may have clinical 
significance as a potential therapeutic agent to decrease ENS hyper-excitability 












1. Furness, J.B., The enteric nervous system and neurogastroenterology. 
Nat Rev Gastroenterol Hepatol, 2012. 9(5): p. 286-94. 
2. Costa, M. and J.B. Furness, The origins, pathways and terminations of 
neurons with VIP-like immunoreactivity in the guinea-pig small intestine. 
Neuroscience, 1983. 8(4): p. 665-76. 
3. Riegler, M., et al., Neurotensin stimulates Cl(-) secretion in human colonic 
mucosa In vitro: role of adenosine. Gastroenterology, 2000. 119(2): p. 
348-57. 
4. Schulzke, J.D., et al., Ion transport and enteric nervous system (ENS) in 
rat rectal colon: Mechanical stretch causes electrogenic Cl-secretion via 
Plexus Meissner and amiloride-sensitive electrogenic Na-absorption is not 
affected by intramural neurons. Pflügers Archiv European Journal of 
Physiology, 1989. 414(2): p. 216-221. 
5. Szurszewski, J.H., A migrating electric complex of canine small intestine. 
Am J Physiol, 1969. 217(6): p. 1757-63. 
6. Kenny, S.E., P.K. Tam, and M. Garcia-Barcelo, Hirschsprung's disease. 
Semin Pediatr Surg, 2010. 19(3): p. 194-200. 
7. Lakhan, S.E. and A. Kirchgessner, Neuroinflammation in inflammatory 
bowel disease. J Neuroinflammation, 2010. 7: p. 37. 
8. Lundgren, O., et al., Role of the enteric nervous system in the fluid and 
electrolyte secretion of rotavirus diarrhea. Science, 2000. 287(5452): p. 
491-5. 
	97	
9. Houghton, L.A., J.M. Foster, and P.J. Whorwell, Alosetron, a 5-HT3 
receptor antagonist, delays colonic transit in patients with irritable bowel 
syndrome and healthy volunteers. Aliment Pharmacol Ther, 2000. 14(6): 
p. 775-82. 
10. Linden, D.R., K.A. Sharkey, and G.M. Mawe, Enhanced excitability of 
myenteric AH neurones in the inflamed guinea-pig distal colon. J Physiol, 
2003. 547(Pt 2): p. 589-601. 
11. Koussoulas, K., et al., Cholera toxin induces sustained hyperexcitability in 
myenteric, but not submucosal, AH neurons in guinea pig jejunum. 
Gastroenterology, 2017. 136(1): p. 299-308 e4. 
12. Franks, C.J., et al., Ionic basis of the resting membrane potential and 
action potential in the pharyngeal muscle of Caenorhabditis elegans. J 
Neurophysiol, 2002. 87(2): p. 954-61. 
13. Ng, F.L., et al., Expression and function of the K+ channel KCNQ genes in 
human arteries. Br J Pharmacol, 2011. 162(1): p. 42-53. 
14. Shah, M.M., et al., Functional significance of axonal Kv7 channels in 
hippocampal pyramidal neurons. Proc Natl Acad Sci U S A, 2008. 
105(22): p. 7869-74. 
15. Anderson, U.A., C. Carson, and K.D. McCloskey, KCNQ currents and their 
contribution to resting membrane potential and the excitability of interstitial 
cells of Cajal from the guinea pig bladder. J Urol, 2009. 182(1): p. 330-6. 
16. Brown, D.A. and G.M. Passmore, Neural KCNQ (Kv7) channels. Br J 
Pharmacol, 2009. 156(8): p. 1185-95. 
	98	
17. Wang, Z.P., Wenmei Shi, Barry S. Brown,Randy S. Wymore, Ira S. 
Cohen, Jane E. Dixon,* David McKinnon, KCNQ2 and KCNQ3 Potassium 
Channel Subunits: Molecular Correlates of the M-Channel. Science, 1998. 
282(5395): p. 1890-1893. 
18. King, C.H., et al., Kv7.2 regulates the function of peripheral sensory 
neurons. J Comp Neurol, 2014. 522(14): p. 3262-80. 
19. Peters, H.C., et al., Conditional transgenic suppression of M channels in 
mouse brain reveals functions in neuronal excitability, resonance and 
behavior. Nat Neurosci, 2005. 8(1): p. 51-60. 
20. Roche, J.P., et al., Antibodies and a cysteine-modifying reagent show 
correspondence of M current in neurons to KCNQ2 and KCNQ3 K + 
channels. British Journal of Pharmacology, 2002. 137(8): p. 1173-1186. 
21. Bi, Y., et al., Visceral hyperalgesia induced by forebrain-specific 
suppression of native Kv7/KCNQ/M-current in mice. Mol Pain, 2011. 7: p. 
84. 
22. Watanabe, H., et al., Disruption of the epilepsy KCNQ2 gene results in 
neural hyperexcitability. J Neurochem, 2000. 75(1): p. 28-33. 
23. Peiris, M., et al., Peripheral KV7 channels regulate visceral sensory 
function in mouse and human colon. Mol Pain, 2017. 13: p. 
1744806917709371. 
24. Rottgen, T.S., et al., Dextran Sulfate Sodium (DSS)-induced Chronic 
Colitis Attenuates Ca(2+)-activated Cl(-) Secretion in Murine Colon by 
Down-regulating TMEM16A. Am J Physiol Cell Physiol, 2018. 
	99	
25. Belai, A., J. Lincoln, and G. Burnstock, Lack of release of vasoactive 
intestinal polypeptide and calcitonin gene-related peptide during electrical 
stimulation of enteric nerves in streptozotocin-diabetic rats. 
Gastroenterology, 1987. 93(5): p. 1034-40. 
26. Kostyuk, P.G., N.S. Veselovsky, and A.Y. Tsyndrenko, Ionic currents in 
the somatic membrane of rat dorsal root ganglion neurons-I. Sodium 
currents. Neuroscience, 1981. 6(12): p. 2423-30. 
27. Kuwahara, A. and H.J. Radowicz-Cooke, Epithelial transport in guinea-pig 
proximal colon: influence of enteric neurones. J Physiol, 1988. 395: p. 
271-84. 
28. Stutts, M.J., et al., Activation of CFTR Cl- conductance in polarized T84 
cells by luminal extracellular ATP. Am J Physiol, 1995. 268(2 Pt 1): p. 
C425-33. 
29. Sun, H., et al., Tgf-beta downregulation of distinct chloride channels in 
cystic fibrosis-affected epithelia. PLoS One, 2014. 9(9): p. e106842. 
30. Dharmsathaphorn, K., et al., A human colonic tumor cell line that 
maintains vectorial electrolyte transport. Am J Physiol, 1984. 246(2 Pt 1): 
p. G204-8. 
31. Boehlen, A., et al., The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-
yl)-benzamid displays anticonvulsant potential. Br J Pharmacol, 2013. 
168(5): p. 1182-200. 
	100	
32. Sheldon, R.J., et al., Pharmacological characterization of neural 
mechanisms regulating mucosal ion transport in mouse jejunum. J 
Pharmacol Exp Ther, 1989. 249(2): p. 572-82. 
33. Kunzelmann, K., et al., Cloning and function of the rat colonic epithelial K+ 
channel KVLQT1. J Membr Biol, 2001. 179(2): p. 155-64. 
34. MacVinish, L.J., et al., Importance of basolateral K+ conductance in 
maintaining Cl- secretion in murine nasal and colonic epithelia. J Physiol, 
1998. 510 ( Pt 1): p. 237-47. 
35. Mall, M., et al., Role of K(V)LQT1 in cyclic adenosine monophosphate-
mediated Cl(-) secretion in human airway epithelia. Am J Respir Cell Mol 
Biol, 2000. 23(3): p. 283-9. 
36. Grahammer, F., et al., The small conductance K+ channel, KCNQ1: 
expression, function, and subunit composition in murine trachea. J Biol 
Chem, 2001. 276(45): p. 42268-75. 
37. Schroeder, B.C., et al., A constitutively open potassium channel formed by 
KCNQ1 and KCNE3. Nature, 2000. 403(6766): p. 196-9. 
38. Qu, Z.D., et al., Immunohistochemical analysis of neuron types in the 
mouse small intestine. Cell Tissue Res, 2008. 334(2): p. 147-61. 
39. Chandan, R., et al., Cholinergic neurons and muscarinic receptors 
regulate anion secretion in pig distal jejunum. Eur J Pharmacol, 1991. 
193(3): p. 265-73. 
	101	
40. Chandan, R., et al., Muscarinic cholinergic regulation of electrogenic 
chloride secretion in porcine proximal jejunum. J Pharmacol Exp Ther, 
1991. 257(2): p. 908-17. 
41. Palmer, J., Wong-Riley Margaret, Sharkey Keith, Functional alterations in 
jejunal myenteric neurons during inflammation in nematode-infected 
guinea pigs. American Journal of Physiology, 1998. 275(38): p. 922-935. 
42. Gallo-Torres, H., A. Brinker, and M. Avigan, Alosetron: ischemic colitis and 
serious complications of constipation. Am J Gastroenterol, 2006. 101(5): 
p. 1080-3. 
43. Page, J.G. and G.M. Dirnberger, Treatment of the irritable bowel 
syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol, 
1981. 3(2): p. 153-6. 
44. Michel, M.C., et al., Unexpected frequent hepatotoxicity of a prescription 
drug, flupirtine, marketed for about 30 years. Br J Clin Pharmacol, 2012. 
73(5): p. 821-5. 
45. Jepps, T.A., et al., Molecular and functional characterization of Kv7 K+ 
channel in murine gastrointestinal smooth muscles. Am J Physiol 




Figure 1. Basolateral 100 µM Flupirtine Inhibits ISC in the Murine Distal 
Colon. A. Representative trace of basolateral application of 1 µM tetrodotoxin 
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(TTX) on full thickness tissue preparation in the Ussing chamber. TTX was able 
to decrease ISC, however addition of basolateral 100 µM flupirtine (Flu) following 
the TTX-induced plateau only modestly decreased ISC. B. Representative trace of 
basolateral application of 100 µM Flu in the Ussing chamber. Measured ISC 
substantially decreased from the previous baseline, however application of 1 µM 
TTX only slightly decreased measured ISC. C. Group data of percent inhibition of 
maximal response of 1 µM TTX prior to 100 µM Flu. D. Group data of percent 
inhibition of maximal response of 100 µM Flu prior to 1 µM TTX application. E. 
Group data of percent inhibition of maximal response of 100 µM Flu prior to or 
following TTX application. All presented bar graphs are summarized data of 
means ± SE from five different animals (n=5). Plotted points on each bar graph 
are representative of individual experiments. *p < 0.001 – compared to control.  
 
Figure 2. Dose-Response of Basolateral application of Flupirtine in Murine 
Distal Colon. A. Representative trace of a dose-response curve of Flu. The 
initial administered concentration of Flu was 100 nM and increased sequentially 
by a log order of 10 until reaching a final concentration of 100 µM Flu. Each 
arrow within the trace indicates time of administration of an individual dose of Flu. 
B. A dose-response curve of percent inhibition of maximal response was 
generated from multiple experiments (n=5) to determine an approximate half-
maximal inhibitory concentration (IC50) in the murine distal colon. 
 
	103	
Figure 3.  Tolterodine and Flupirtine Inhibit Cholinergic-induced ISC in the 
Distal Colon. A. Representative trace of basolateral application of 10 µM 
tolterodine (TOL) followed by basolateral 100 µM Flu on whole-mount distal colon 
in the Ussing chamber. B. Representative trace of basolateral application of 100 
µM Flu followed by 10 µM TOL in the Ussing chamber. C. Group data of percent 
inhibition of maximal response of 10 µM TOL prior to Flu application. D. Group 
data of percent inhibition of maximal response of 100 µM Flu prior to application 
10 µM TOL. E. Group data of percent inhibition of maximal response of 100 µM 
Flu prior to or following 10 µM TOL application. All presented bar graphs 
represent summarized data of means ± SE from five different animals (n=5). 
Plotted points on each bar graph represent individual experiments that contribute 
to the overall mean and SE. *p < 0.001 
 
Figure 4. Flupirtine Inhibits Nicotine-Induced Increases in ISC. 
 A. Representative trace of basolateral 100 µM nicotine (NICO)-induced 
increases in measured ISC in the distal colon. B. Representative trace of 100 µM 
NICO-induced increases in ISC that was pre-incubated with 100 µM Flu. C. Group 
data of NICO-induced ΔISC in tissue that was pre-incubated with or without 100 
µM Flu prior to basolateral 100 µM NICO administration. All presented bar 
graphs represent summarized data of means ± SE from five different animals 
(n=5). Plotted points on each bar graph represent individual experiments that 
contribute to the overall mean and SE. *p < 0.001 
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Figure 5. Flupirtine Does Not Decrease Isc in T84 Monolayers. A. 
Representative trace of measured ISC in T84 monolayers that were treated with 
basolateral 100 µM Flu. Monolayers were then stimulated with 10 µM forskolin 
(FSK) that was inhibited with 50 µM XE-991 upon reaching a steady-state. B. 
Representative trace of measured ISC in T84 monolayers that were incubated with 
1 µM TTX. Monolayers were then stimulated with 10 µM FSK and then inhibited 
with 50 µM XE-991. C. Group data of measured ΔISC following either 100 µM Flu 
or 1 µM TTX. D. Group data of 10 µM FSK-induced ΔISC from T84 monolayers 
incubated with Flu or TTX. All presented bar graphs represent summarized data 
of means ± SE from five different animals (n=5). Plotted points on each bar graph 
represent individual experiments that contribute to the overall mean and SE. *p < 
0.001 
 
Figure 6. Kv7.2 and KV7.3 Co-Localize with Choline Acetyl Transferase in 
Enteric Neurons of the Murine Distal Colon. A/D. Axons of enteric neurons 
that stained positive for choline acetyl transferase (ChAT). B/E. Positive immuno-
staining for KV7.2 and KV7.3 in murine distal colon. C/F. Merged images of 
panels A/B and D/E demonstrate co-localization of KV7.2 and KV7.3 with axons 
positively-stained for ChAT. 
 
Figure 7. The Specific KV7.2/3 Activator, ICA 110381, Inhibits ISC in the 
Murine Distal Colon. A. Representative trace of measured ISC that has been 
administered 100 µM ICA 110381(ICA) to the basolateral surface. This was then 
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followed by 1 µM TTX application, which was also applied to the basolateral 
surface. B. Group data of percent inhibition of maximal response of tissues that 
received basolateral 100 µM ICA prior to 1 µM TTX. C. Representative trace of a 
dose-response curve that was sequentially administered 100 nM ICA, increasing 
by a factor of ten each time, with a final basolateral concentration of 100 µM ICA. 
Each arrow indicates the time of administration of each corresponding 
concentration of ICA. D. A dose-response of percent inhibition of maximal 
response from multiple experiments (n=5) was generated to determine the IC50 of 
ICA. All presented bar graphs represent summarized data of means ± SE from 
five different animals (n=5). Plotted points on each bar graph represent individual 































































































































































































































































































































































































































































































































































































































































































































As previously presented, I have demonstrated that the absence of Ca2+-
activated Cl- secretion in DSS-treated animals is a result of decreased 
expression of TMEM16A in colonic epithelium. I have also shown that activation 
of KCNQ2/3 and the resultant hyperpolarization in enteric neurons can inhibit 
mucosal Cl- secretion. Each of these are novel findings and contribute to their 
respective fields. The following discussion will elaborate on their greater 
implications with a specific focus on inflammatory bowel disease.  
	
TMEM16A and Dextran-Sulfate Sodium-Induced Colitis 
 
As previously discussed, the DSS-induced colitis is a commonly utilized 
animal model of inflammatory bowel disease (IBD) [1]. It has previously been 
shown that the colitis that develops significantly blunts apical Cl- secretion in the 
distal colon [2]. More specifically though, agonists that elicit increases in 
intracellular Ca2+ and resultant Cl- secretion have been shown to be completely 
abolished. Stimulation with agonists that normally increase ISC actually lead to a 
decrease following DSS treatment. Previous studies that focused on this 
phenomenon attributed these changes to a dysfunctioning ENS or alterations in 
the basolateral K+ conductance [3, 4]. However, these studies were prior to the 
identification of TMEM16A, a CaCC. Our group was the first to reexamine this 
previously observed effect of DSS-induced colitis, and we were able to determine 
that TMEM16A was in fact down-regulated in the DSS-induced colitis model. Our 
functional data demonstrated that CCH-induced Cl- secretion in DSS animals 
was not only abolished, but it had reversed in its direction of polarity, similar to 
previous reports. Also, the use of a Ca2+ ionophore (ionomycin) was able to 
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reproduce a similar ISC profile to that of CCH, indicating this mechanism is 
mediated via Ca2+. However, most important of all the findings was the 
quantification of TMEM16A via immunoblot. Immunoblot analysis demonstrated a 
significant reduction in total TMEM16A in colonic epithelium. 
Immunohistochemistry also demonstrated that the remaining protein was not 
properly trafficked to the cellular membrane in colonic epithelium.  
 While this seems to answer the question as to why Ca2+-activated Cl- 
secretion is absent in DSS-exposed animals, it does not solve the entire riddle. 
The mechanism by which TMEM16A is down-regulated in colonic epithelium 
following DSS-exposure is still unknown. However, several groups have 
previously demonstrated that Ca2+-activated Cl- secretion could be decreased 
following incubation with certain cytokines in immortalized cell lines of colonic 
epithelium [5, 6]. Both cytokines (IL-4 and TGF-β) that decreased Ca2+-activated 
Cl- secretion are more typically represented in a Th2-mediated immune response. 
Since, the utilization of the Balb/c mice in our study typically respond in more of a 
Th2 response (and our qPCR results would indicate as such), this may be the 
reason for loss of TMEM16A protein expression. With this as our working 
hypothesis, it would be interesting to repeat this study in C57Bl/6 mice, which 
typically demonstrate a Th1 response upon DSS exposure, and determine if they 
would demonstrate a protection against loss of TMEM16A. Also, colon specific-
knockout of TGF-β or IL-4 in combination with DSS-induction could potentially 
provide some protective mechanism by preventing signaling through either 
cellular pathway. 
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 While signaling through a Th2 immune response may be a likely cause for 
down-regulation of TMEM16A, the most important question to answer is, ‘Does 
down-regulation of TMEM16A have any role in the development of or 
continuance of inflammation in DSS-colitis, or for that matter IBD?”. The 
evidence for this is much less than is present to even support the previously 
proposed mechanism whereby TMEM16A is down-regulated in colonic 
epithelium. However, it has been shown previously that Ca2+-activated Cl- 
secretion decreases in the first couple days of DSS-exposure even though 
physical symptoms such as loose stools with copious amounts of mucus do not 
manifest until about day 5 of a one week exposure [1]. Also, animals treated with 
DSS have disrupted mucus barriers that typically prevent interaction between the 
host and the microbiome [7]. It has been demonstrated that activation of 
TMEM16A is crucial for release of Muc5AC, however that study was conducted 
in human bronchial epithelial cells [8]. Muc5AC and similar proteins like it are 
necessary for maintaining the mucosal mucus barrier. Applying this knowledge, it 
is plausible that down-regulation of TMEM16A in DSS-colitis or potentially IBD 
could cause a decrease in Muc2 protein (more common in the intestine) 
secretion and overall disruption in the mucus barrier lining the colonic lumen. 
This would eventually lead to increased interaction between the microbiome and 
the host, which would elicit an inflammatory response. While this is highly 




KCNQ2/3 and the Enteric Nervous System 
 The ENS has a vast supply of neurons along the entire gastrointestinal 
tract. Previous research has demonstrated that the ENS can control local blood 
flow, motility of the tract, and influence electrolyte transport [9]. As far as ENS 
control over electrolyte transport, previous studies have demonstrated that 
application of TTX (NaV inhibitor) or atropine (muscarinic antagonist) inhibits on-
going Cl- secretion via inhibition of ISC [10, 11]. Our study was similar in setup, 
however, we focused on KCNQ channels and their contribution to resting 
membrane potential in enteric neurons. Activation of KCNQ channels with 
basolateral flupirtine was able to inhibit the observed ISC in full thickness tissue 
from murine distal colon. This was achieved via inhibition of neurotransmitter 
release from enteric neurons that were substantially hyperpolarized. Application 
of TTX following flupirtine was practically unable to decrease the measured ISC. 
Also, pre-incubation with flupirtine prior to stimulation with nicotine resulted in an 
unresponsiveness of the tissue. Application of flupirtine on the T84 colonic 
epithelial cell line further implicated that effect was mediated through the ENS, 
since the monolayers were unresponsive to the drug. However, flupirtine is a 
non-specific activator of KCNQ channels, therefore the use of 
immunofluorescence was employed to demonstrate the presence of KCNQ2 and 
KCNQ3 in enteric neurons. 
 The previously mentioned work seems to indicate that activation of KCNQ 
channels in enteric neurons can lead to inhibition of neurotransmitter release. 
Unfortunately, functional evidence of the exact channels that contribute to the 
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observed response is lacking. While the use of a specific activator of KCNQ2/3 
was utilized in the study, channel activators are prone to selectivity issues. A 
specific inhibitor to the channel would be of clear benefit to the study and future 
research. However, the only available KCNQ inhibitors are linopiridine and XE-
991, which are both global KCNQ inhibitors. This means that a specific channel 
can not be identified from inhibition with either of the drugs. Also, KCNQ1 has 
been characterized to reside on the basolateral membrane of colonic epithelium 
and inhibition causes decreased apical Cl- secretion due to loss of a favorable 
electrochemical gradient [12, 13]. So, application of either of the inhibitors causes 
a decrease in ISC, when one might expect an increase due to increased firing of 
enteric neurons. Hopefully in the future better pharmacological tools (inhibitors) 
can be developed that will allow for this functional characterization, or the 
development of a conditional knock-out model with an enteric neuron promoter. 
 
The Enteric Nervous System And Inflammatory Bowel Disease 
 While seemingly disconnected, the two previously presented studies have 
a potential common thread of IBD. Research has primarily focused on the 
immune response that is present within the tissue, as well as, the changes in 
electrolyte transport across the epithelial layer. However, it has been shown that 
inflammation is able to elicit a hyper-excitability of enteric neurons [14, 15]. It 
would be of personal future interest to evaluate the effects of DSS administration 
on the ENS from the standpoint of electrolyte transport and epithelial integrity. I 
would be curious to see if oral administration of KCNQ activators is capable of 
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attenuating the deleterious effects of DSS-colitis and for that matter IBD as a 
whole. Also, utilization of animal models with dysfunctional enteric KCNQ 
channels with DSS administration would be interesting to characterize the 
severity of colitis as well as alterations in epithelial transport. Hopefully in the 
near future, activators truly specific to KCNQ2/3 will become available and allow 
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